nct_id,last_update_submitted_date,start_month_year,completion_month_year,primary_completion_month_year,study_first_submitted_date,results_first_submitted_date,study_type,phase,enrollment,overall_status,official_title,brief_title
NCT00000751,2008-09-26,NA,August 2007,NA,1999-11-02,NA,Interventional,Phase 3,1600,Completed,"A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)","A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)"
NCT00000758,2021-10-27,NA,April 1998,NA,1999-11-02,NA,Interventional,Phase 3,158,Completed,"A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women","A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women"
NCT00000777,2021-10-27,NA,July 1998,NA,1999-11-02,NA,Interventional,Phase 1,24,Completed,"Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)","Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)"
NCT00000808,2021-10-27,NA,September 1998,NA,1999-11-02,NA,Interventional,Phase 1,49,Completed,A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers,A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers
NCT00000828,2005-06-23,NA,NA,NA,1999-11-02,NA,Observational,NA,250,Completed,Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine,Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
NCT00000839,2021-10-27,NA,June 2001,NA,1999-11-02,NA,Interventional,Phase 1,12,Completed,A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women,A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women
NCT00000862,2021-10-27,NA,November 2003,NA,1999-11-02,NA,Interventional,Phase 1,36,Completed,A Phase I Trial of the Pharmacokinetics and Tolerance of Oral Zidovudine Administered to HIV-1 Infected Pregnant Women During Labor and Delivery,A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women
NCT00000887,2021-10-27,NA,July 2004,NA,1999-11-02,NA,Interventional,Phase 1,24,Completed,"A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Nelfinavir (Viracept) Co-Administered With Zidovudine (ZDV) and Lamivudine (3TC) in HIV Infected Pregnant Women and Their Infants",A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
NCT00000888,2021-10-27,NA,April 2001,NA,1999-11-02,NA,Interventional,Phase 1,14,Completed,"A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Ritonavir Co-Administered With Lamivudine (3TC) and Zidovudine (ZDV) in HIV-1-Infected Pregnant Women and Their Infants",Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies
NCT00000944,2021-10-27,NA,March 2003,NA,1999-11-02,NA,Interventional,Phase 1,24,Completed,"A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Indinavir Co-Administered With Lamivudine (3TC) and Zidovudine (ZDV) in HIV-1-Infected Pregnant Women During Gestation and Post Partum, and in Their Infants Post Maternal Dosing","A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants"
NCT00001041,2021-10-28,NA,July 1998,NA,1999-11-02,NA,Interventional,Phase 1,24,Completed,"Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)","Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)"
NCT00001046,2021-10-28,NA,NA,NA,1999-11-02,NA,Interventional,Phase 1,0,Withdrawn,Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo),Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
NCT00017719,2021-10-28,May 2002,March 2006,NA,2001-06-08,NA,Interventional,Phase 3,440,Completed,Randomized Trial of Protease Inhibitor-Including vs. Protease Inhibitor-Sparing Regimens for Women Who Initiate Therapy of HIV Infection During Pregnancy,Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
NCT00017797,2006-08-03,NA,NA,NA,2001-06-12,NA,Observational,NA,160,Completed,Evaluation of Metabolic Complications Associated With Antiretroviral Medications in HIV-1-Infected Pregnant Women,Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
NCT00021671,2021-10-28,NA,November 2004,NA,2001-07-31,NA,Interventional,Phase 3,3720,Completed,Phase III Trial of Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission,Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
NCT00028145,2014-10-08,October 2002,June 2013,June 2013,2001-12-13,NA,Observational,NA,3090,Completed,Perinatal Core Protocol,Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00041964,2012-07-23,NA,NA,NA,2002-07-19,NA,Observational,NA,129,Completed,A Prospective Observational Study of Virologic and Immunologic Changes in HIV-Infected Women During the Postpartum Period,A Study of HIV Levels During Pregnancy and After Childbirth
NCT00046436,2013-05-31,NA,March 2004,NA,2002-09-30,NA,Observational,NA,7500,Terminated,Mother-Infant Rapid Intervention at Delivery (MIRIAD),Rapid HIV Tests for Women Late in Pregnancy and During Labor
NCT00054041,2013-01-23,June 2004,NA,January 2007,2003-02-05,NA,Interventional,Phase 2,84,Completed,"Phase II Evaluation Of SGN-00101 (HSP-E7) Fusion Protein In Women With Cervical Intraepithelial Neoplasia 3, CIN 3",Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
NCT00067249,2007-02-26,April 2001,September 2001,NA,2003-08-13,NA,Observational,NA,3200,Completed,NA,Women's Use of Alternative Medicine: A Multiethnic Study
NCT00068120,2010-01-12,NA,NA,NA,2003-09-08,NA,Observational,NA,200,Completed,ORWH:SCOR - Sex/Gender Factors Affecting Women's Health,ORWH:SCOR - Sex/Gender Factors Affecting Women's Health
NCT00070746,2014-07-29,June 2003,July 2005,NA,2003-10-07,NA,Observational,NA,1500,Completed,"Perinatal Infections and Pregnancy Outcomes in Pakistan: A Collaborative Research Project in Partnership With the University of Alabama, USA",Perinatal Infections in Pakistan
NCT00087828,2006-08-16,November 2000,June 2005,NA,2004-07-14,NA,Interventional,Not Applicable,5,Completed,Cranberry Juice Metabolites in Urine,Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections
NCT00091130,2013-05-31,September 2004,NA,June 2007,2004-09-07,NA,Interventional,Phase 2,139,Completed,"An Exploratory Study to Evaluate the Effect of HPV 16 Vaccine on the Reduction of Viral Load in HPV 16 Positive Women With Persistent Viral Infection, But Low Grade Disease (ASCUS/LSIL)",SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells
NCT00093054,2015-04-14,November 2004,December 2009,March 2008,2004-09-30,NA,Interventional,Phase 2/Phase 3,319,Completed,Cranberry Juice and Urinary Tract Infections,Cranberry Juice for Treatment of Urinary Tract Infections
NCT00093938,2010-01-12,December 2004,NA,NA,2004-10-07,NA,Interventional,Phase 1,360,Completed,Cranberry for Prevention of Bacteriuria in Pregnancy,Cranberry Juice for Preventing Bacteria in Urine During Pregnancy
NCT00100061,2013-03-11,May 2007,July 2013,July 2013,2004-12-22,NA,Interventional,Phase 2,350,Unknown status,Dose Response to Cranberry of Women With Recurrent UTIs,Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)
NCT00114712,2020-12-10,January 2004,"November 2, 2020","November 2, 2020",2005-06-16,NA,Observational [Patient Registry],NA,477,Terminated,The Ribavirin Pregnancy Registry,The Ribavirin Pregnancy Registry
NCT00115388,2014-11-21,September 2004,December 2008,December 2008,2005-06-21,NA,Interventional,Not Applicable,2531,Completed,Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease,Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
NCT00116974,2016-08-12,October 2004,February 2009,February 2009,2005-06-30,NA,Interventional,Phase 3,2100,Terminated,Periodontal Infection and Prematurity Study,Periodontal Infection and Prematurity Study
NCT00121797,2006-11-06,January 2004,June 2005,NA,2005-07-17,NA,Interventional,Not Applicable,1000,Unknown status,"Risk Factors for Postpartum Bacteruria, Does Labor Cause UTI?",Peripartum Bacteruria and Urinary Tract Infections (UTI)
NCT00128128,2015-05-14,August 2005,June 2009,December 2008,2005-08-05,NA,Interventional,Phase 2,176,Completed,Cranberry and Prevention of UTI A Comprehensive Approach,Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections
NCT00128661,2019-02-12,"June 30, 2004","December 31, 2010","December 31, 2010",2005-08-08,2011-12-15,Interventional,Phase 3,7466,Completed,"A Double-Blind, Controlled, Randomized, Phase III Study of the Efficacy of an HPV16/18 VLP Vaccine in the Prevention of Advanced Cervical Intraepithelial Neoplasia (CIN2, CIN3, Adenocarcinoma In Situ [AIS] and Invasive Cervical Cancer) Associated With HPV 16 or HPV 18 Cervical Infection in Healthy Young Adult Women in Costa Rica.",Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
NCT00136370,2007-09-21,April 2004,November 2007,NA,2005-08-25,NA,Interventional,Phase 3,8000,Unknown status,"Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa",Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn
NCT00158509,2006-06-06,August 2004,July 2005,NA,2005-09-09,NA,Interventional,Phase 2,215,Completed,Efficacy of an HSV2 Genital Herpes Suppressive Treatment on HIV and HSV2 Genital Shedding Among Co-Infected Patients Receiving or Not Antiretroviral Drugs,Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding
NCT00186082,2011-06-13,September 2003,June 2008,June 2006,2005-09-13,NA,Interventional,Not Applicable,147,Completed,A Randomized Controlled Trial of the Effect of Prophylactic Antibiotics on the Infection Rate in Postpartum Third and Fourth Degree Perineal Tear Repairs,Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs
NCT00194142,2016-08-15,July 2007,May 2008,May 2008,2005-09-12,NA,Observational,NA,37,Completed,NA,Cytomegalovirus (CMV) Infection in Amniotic Fluid
NCT00194155,2016-08-15,May 2003,February 2008,February 2008,2005-09-12,NA,Observational,NA,283,Completed,Cytomegalovirus Infection and Pregnancy Outcomes,Cytomegalovirus (CMV) Infection in Pregnancy
NCT00194311,2016-08-15,April 2005,August 2007,August 2007,2005-09-13,NA,Observational,NA,620,Completed,NA,Human Papillomavirus (HPV) Infection in Pregnancy
NCT00194532,2014-06-03,June 2005,February 2009,February 2009,2005-09-13,2011-03-30,Interventional,Not Applicable,300,Completed,Cefpodoxime vs Ciprofloxacin for Acute Cystitis,Cefpodoxime vs Ciprofloxacin for Acute Cystitis
NCT00197561,2010-11-09,September 2003,August 2006,August 2006,2005-09-12,NA,Interventional,Phase 3,915,Completed,Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection,Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection
NCT00213018,2017-08-11,October 1999,January 2002,NA,2005-09-13,NA,Interventional,Phase 2,400,Completed,"A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing STI/HIV Transmission","Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission"
NCT00213031,2017-08-11,February 2000,December 2001,NA,2005-09-13,NA,Interventional,Phase 2,165,Completed,"A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of PC-515 (Lambda Carrageenan) for Vaginal Use as a Possible Microbicide","Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide"
NCT00214045,2019-05-01,July 2004,June 2009,June 2009,2005-09-13,2016-01-08,Interventional,Not Applicable,36,Completed,Rigid Versus Flexible Cystoscopy in Women in Outpatient Clinic,Rigid Versus Flexible Cystoscopy in Women
NCT00216853,2009-04-15,September 2003,March 2007,June 2006,2005-09-19,NA,Observational,NA,44,Completed,A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection,A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection
NCT00239161,2005-10-12,September 2004,July 2005,NA,2005-10-12,NA,Interventional,Phase 4,30,Terminated,TREATMENT OF ACUTE UNCOMPLICATED PYELONEPHRITIS WITH SHORT COURSE LEVOFLOXACIN A Pilot Study,Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin
NCT00261248,2015-10-01,November 1996,December 2003,NA,2005-11-30,NA,Interventional,Phase 2,75,Completed,Phase 2 Clinical Trial of Vaginal Mucosal Immunization for Recurrent Urinary Tract Infections,Vaccine for Recurrent Urinary Tract Infections in Women
NCT00262106,2012-09-05,October 2005,September 2009,August 2008,2005-12-05,NA,Interventional,Phase 3,9404,Completed,"An International Multi-centre, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 0.5% and 2% PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection",Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
NCT00270530,2006-01-30,November 2002,October 2004,NA,2005-12-23,NA,Interventional,Phase 4,454,Completed,Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia,Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
NCT00303823,2015-04-14,September 2005,February 2011,November 2010,2006-03-15,2012-07-13,Interventional,Phase 2,98,Completed,A Phase II Trial of Polyphenon E for Cervical Cancer Prevention,Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
NCT00305071,2006-03-19,April 2006,NA,NA,2006-03-19,NA,Interventional,Phase 2,60,Unknown status,"A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets (UmayC) in Acute Bacterial Cystitis.",Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
NCT00305227,2023-03-18,March 2006,April 2012,April 2012,2006-03-20,2014-06-03,Interventional,Phase 2,100,Completed,Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections,Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
NCT00316706,2012-09-13,October 2005,January 2009,January 2009,2006-04-19,2009-11-12,Interventional,Phase 3,1245,Completed,"A Long-term, Open Follow-up of the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine (580299) in Healthy Female Subjects Vaccinated in Study HPV-013",Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
NCT00330278,2007-09-26,January 2003,January 2006,NA,2006-05-25,NA,Interventional,Not Applicable,350,Completed,"A Randomized, Double-Blind, Placebo Controlled Trial of Cefazolin Given Either 30 Minutes Prior to Cesarean Section or at Cord Clamping",Timing of Prophylactic Antibiotics for Cesarean Sections
NCT00337818,2017-05-25,June 2006,January 2009,June 2006,2006-06-15,2009-11-12,Interventional,Phase 3,770,Completed,"A Long-term, Open, Follow-up of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV-16/18 L1/AS04 Vaccine in Healthy Female Subjects Vaccinated Either Pre- or Post-menarche in the Primary Study",Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
NCT00352300,2014-12-29,June 2006,NA,July 2010,2006-07-13,NA,Interventional,Phase 1,43,Completed,"A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined With Paclitaxel and Pegfilgrastim (Neulasta): A Feasibility Study in Patients With Untreated Stage III and IV Ovarian, Tubal or Primary Peritoneal Cancer","Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer"
NCT00353561,2008-05-21,June 2004,April 2006,April 2006,2006-07-17,NA,Interventional,Phase 3,100,Completed,Diabetes Mellitus and Vulvovaginal Candidiasis: Prevalence of Infection and Its Rationale Management,Diabetes Mellitus and Vulvovaginal Candidiasis
NCT00353743,2008-12-18,May 2006,December 2007,November 2007,2006-07-13,NA,Interventional,Not Applicable,56,Terminated,A Randomized Clinical Trial on the Use or Not of Antibiotics After Hospital Discharge in Septic Abortion.,The Use of Antibiotics After Hospital Discharge in Septic Abortion
NCT00365716,2015-10-06,May 2000,September 2009,May 2004,2006-08-16,2010-05-19,Interventional,Phase 2,1158,Completed,"A Placebo-Controlled, Dose-Ranging Study of Quadrivalent HPV Virus-Like Particle (VLP) Vaccine in 16- to 23-Year-Old Women","Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)"
NCT00376493,2008-03-10,May 2006,December 2007,December 2007,2006-09-14,NA,Interventional,Phase 4,56,Terminated,Prolonged Treatment for Infected Abortion After Hospital Discharge.,Prolonged Treatment for Infected Abortion After Hospital Discharge.
NCT00386477,2010-01-14,September 2006,May 2009,May 2009,2006-10-09,2009-11-11,Interventional,Not Applicable,300,Terminated,"Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial","Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial"
NCT00391651,2014-06-03,January 2002,July 2005,July 2005,2006-10-20,NA,Interventional,Phase 2,338,Completed,Short Course Nitrofurantoin For Acute Cystitis,Short Course Nitrofurantoin for Acute Cystitis
NCT00397735,2018-10-08,"October 1, 2006","August 1, 2018","October 29, 2012",2006-11-07,NA,Interventional,Phase 1/Phase 2,68,Completed,Effect of N-acetylcysteine in Preventing Adverse Neonatal Outcomes in Women With Intra-amniotic Infection/Inflammation,N-acetylcysteine in Intra-amniotic Infection/Inflammation
NCT00417365,2007-08-13,August 2006,September 2007,NA,2006-12-28,NA,Interventional,Not Applicable,100,Unknown status,"""A Comparison Study of the WaterWorks® Douching Device vs. Commercial OTC Douching Device for the Reduction or Abatement of Perceived Vaginal Odor With or Without Complaints of Discharge in Women With no Infectious Causes of Vaginitis""",Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis
NCT00453349,2014-09-02,January 2007,May 2008,May 2008,2007-03-27,2009-09-01,Interventional,Phase 3,460,Completed,"A Prospective, Randomized, Double Dummy, Double Blind, Multi-center Multinational Trial Comparing the Efficacy and Safety of Moxifloxacin 400 mg PO QD 24 Hours for 14 Days to That of Levofloxacin 500 mg PO QD 24 Hours Plus Metronidazole 500 mg BID for 14 Days in Subjects With an Uncomplicated Pelvic Inflammatory Disease (PID). Moxifloxacin, Metronidazole, and Levofloxacin in Asia (MONALISA Study)",A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
NCT00520598,2015-11-25,October 2007,May 2011,May 2011,2007-08-22,NA,Interventional,Phase 2,511,Completed,"A Phase IIa Randomized, Double-Blind Controlled With Gardasil, Clinical Trial to Study theTolerability and Immunogenicity of V505 (a Multivalent Human Papilloma Virus [HPV] L1 Virus Like Particle [VLP] Vaccine) in Healthy 16 to 26 Year Old Women",Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
NCT00536848,2009-01-29,October 2007,August 2008,August 2008,2007-09-27,NA,Interventional,Phase 2/Phase 3,65,Unknown status,"The Effect of Probiotic Supplementation With Lactobacillus GR-1 and RC-14,on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients; a Randomised, Placebo Controlled Trial","The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients"
NCT00543543,2018-10-30,"September 24, 2007","July 7, 2016","April 10, 2013",2007-10-12,2014-12-12,Interventional,Phase 3,14840,Completed,"A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16- to 26- Year-Old Women",Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
NCT00551187,2015-06-05,October 2007,May 2009,May 2009,2007-10-29,NA,Interventional,Phase 2,620,Completed,"A Randomized, Double-Blinded, Tolerability and Immunogenicity Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered Concomitantly With GARDASIL to 16- to 26- Year-Old Women",A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
NCT00560924,2017-02-24,"March 21, 2003","March 17, 2004","March 17, 2004",2007-11-19,NA,Interventional,Phase 3,6,Terminated,Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women (RUTI) in Post-menopausal Women With Signs of Urogenital Ageing (UGA),Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women
NCT00564135,2015-06-02,March 2007,July 2008,January 2008,2007-11-25,NA,Interventional,Not Applicable,150,Completed,Postoperative Urinary Retention and UTI After LAVH for Benign Disease,Postoperative Urinary Retention and Urinary Track Infection (UTI) After Laparoscopic Assisted Vaginal Hysterectomy (LAVH) for Benign Disease
NCT00598403,2010-06-28,November 2007,June 2010,December 2009,2008-01-09,NA,Interventional,Phase 3,611,Completed,"Multicentre, Prospective, Comparative, Randomized, Double-blind, Double-dummy Study to Assess the Efficacy and Safety of Cefditoren Pivoxil vs. Ciprofloxacin in Uncomplicated Acute Cystitis",Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis
NCT00603603,2016-06-20,February 2008,May 2010,March 2010,2008-01-17,NA,Interventional,Not Applicable,606,Completed,Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity,Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity
NCT00616330,2012-02-29,January 2008,December 2009,December 2009,2008-02-04,NA,Interventional,Phase 3,1443,Completed,NA,Vaginal Infection Study
NCT00620984,2015-05-29,August 2006,December 2009,August 2009,2008-02-13,NA,Observational,NA,557,Completed,Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis: A Large Prospective Study,Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis
NCT00642070,2014-06-03,February 2008,July 2012,July 2012,2008-03-18,NA,Observational,NA,326,Completed,Host Response to Urinary Tract Infection in Women,Host Response to Urinary Tract Infection in Women
NCT00663806,2014-12-01,February 2003,July 2003,NA,2008-04-17,NA,Interventional,Phase 4,7614,Completed,"EXPRESS: Evaluating Cipro XR Patient Response, Education, Safety, and Satisfaction",A Phase IV Study of Cipro XR in Uncomplicated UTI
NCT00669994,2014-12-18,July 2003,October 2003,NA,2008-04-29,NA,Interventional,Phase 4,180,Completed,"Prospective, Open Label Non-comparative, Multi-center Trial to Evaluate the Efficacy and Safety of Cipro® XR 500 mg Once Daily for 3 Days in Treating Female Patients With Acute, Uncomplicated, Symptomatic Lower Urinary Tract Infections",Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
NCT00670020,2008-04-30,January 2001,December 2006,December 2006,2008-04-29,NA,Interventional,Not Applicable,143,Completed,Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection,Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection
NCT00676533,2013-10-10,June 2003,January 2004,NA,2008-05-09,NA,Interventional,Phase 4,276,Completed,Cipro® XR Excellence in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections,Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
NCT00678028,2009-04-22,February 2008,NA,NA,2008-02-17,NA,Observational,NA,200,Completed,Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection,Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection
NCT00678041,2016-08-03,May 2008,May 2009,May 2009,2008-05-10,2016-05-10,Interventional,Not Applicable,10,Terminated,"A Randomized, Double-blind, Placebo-controlled Trial Examining the Effect of Nitrofurantoin Prophylaxis in Women Performing Clean Intermittent Self-catheterization (CISC) After Surgery for Urinary Incontinence and/or Pelvic Organ Prolapse",Nitrofurantoin and Urinary Tract Infections (UTIs)
NCT00682851,2016-08-15,July 2008,April 2009,April 2009,2008-05-16,2011-07-08,Observational,NA,519,Completed,A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test,A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test
NCT00683865,2014-10-12,April 2003,October 2004,October 2004,2008-05-21,NA,Interventional,Phase 3,749,Completed,"Prospective, Randomized, Double-blind, Multicenter, Multinational Study Comparing Efficacy and Safety of Moxifloxacin 400 mg po od for 14 Days With Ofloxacin 400 mg po Bid Plus Metronidazole 500 mg po Bid for 14 Days in Patients With Uncomplicated Pelvic Inflammatory Disease (PID)",Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.
NCT00700219,2010-07-19,June 2008,September 2010,September 2010,2008-06-13,NA,Observational,NA,900,Unknown status,Development of a Non-invasive Test to Detect Intra-amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and and Intact Amniotic Membranes,Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
NCT00701350,2010-07-19,June 2008,February 2010,February 2010,2008-06-13,NA,Observational,NA,79,Completed,Identification of Proteomic Markers of Intra-amniotic Infection (IAI) in Patients With Preterm Premature Rupture of Amniotic Membranes (PPROM),Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes
NCT00714792,2017-04-26,June 2008,March 2009,March 2009,2008-07-08,2011-09-27,Observational,NA,18,Completed,Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?,Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
NCT00716183,2009-05-22,July 2008,May 2009,July 2008,2008-07-14,NA,Interventional,Phase 2/Phase 3,300,Completed,Phase 2/3 Evaluation of Three Lactobacilli Strains Isolated From Human Milk for the Treatment of Infectious Mastitis During the Lactation Period,Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis
NCT00722735,2009-06-10,October 2008,April 2009,April 2009,2008-07-25,NA,Interventional,Phase 2,36,Completed,"A Double-Blind, Double-Dummy, Prospective, Randomized Multiple-Site Study of Oral Finafloxacin 300 mg b.i.d. Versus Oral Ciprofloxacin 250 mg b.i.d. in Patients With Lower Uncomplicated UTI (uUTI) With a Treatment Duration of 3 Days",Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)
NCT00731315,2015-03-05,August 2008,July 2011,July 2011,2008-08-05,NA,Interventional,Not Applicable,200,Terminated,Computer-Assisted Treatment in the Management of Adult Female Patients With Symptoms of Urinary Tract Infection in Emergency Departments and Community Health Centers: A Randomized Trial,Computer-Assisted Treatment of Urinary Tract Infection in Emergency Departments and Community Health Centers
NCT00734968,2016-08-17,May 2008,May 2010,May 2010,2008-08-12,2016-05-20,Interventional,Phase 4,161,Completed,"Does Prophylaxis With Macrobid Reduce the Incidence of Urinary Tract Infection in Patients Who Receive a Sub-Urethral Sling for the Treatment of Stress Urinary Incontinence: Randomized, Double Blinded Placebo Controlled Clinical Trial",Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence
NCT00740584,2018-10-01,August 2008,March 2009,March 2009,2008-08-21,2012-04-03,Interventional,Phase 1/Phase 2,12,Completed,Assessment of Local Retention and Duration of Activity of SPL7013 Following Vaginal Application of 3% SPL7013 Gel (VivaGel) in Healthy Volunteers,Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
NCT00767988,2015-09-11,NA,NA,NA,2008-10-06,NA,Interventional,Phase 2,0,Withdrawn,Probiotics Improvement of Gastrointestinal and Genitourinary Health in Girls With Spina Bifida (H-23245),Probiotics in Girls With Spina Bifida
NCT00781625,2008-10-29,October 2008,December 2010,December 2009,2008-10-28,NA,Interventional,Not Applicable,120,Unknown status,"Probiotics/Lactobacillus as a Prophylactic Aid in Recurrent Bacterial Cystitis in Women. A Randomized, Prospective, Double-Blinded, Placebo Controlled, Multi-Center Study.",Probiotics as a Prophylactic Aid in Women With Recurrent Urinary Tract Infections (UTI's)
NCT00783419,2023-12-11,March 2007,January 2011,January 2010,2008-10-30,NA,Observational,NA,55,Completed,Rate of Pelvic Inflammatory Disease and Tubo-ovarian Abscess at SMH,Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
NCT00789464,2020-08-14,NA,NA,NA,2008-11-10,NA,Interventional,Phase 2,0,Withdrawn,H-23187: Probiotic Prophylaxis Against Recurrent Pediatric Urinary Tract Infection,Probiotics for Girls With Recurring Urinary Tract Infections
NCT00801021,2010-03-04,December 2008,June 2009,June 2009,2008-12-02,NA,Interventional,Phase 1,3,Completed,Treatment and/or Prevention of Urinary Tract Infections,Treatment and/or Prevention of Urinary Tract Infections
NCT00803127,2009-08-10,January 2009,May 2009,April 2009,2008-12-04,NA,Observational,NA,120,Completed,VS-Sense Result Reading Clarity,VS-Sense Result Reading Clarity
NCT00868621,2009-03-23,March 2007,June 2009,September 2008,2009-03-23,NA,Observational,NA,56,Unknown status,Identification of Urinary Cytokines in Patients With Overactive Bladder (OAB),Urinary Cytokines in Patients With Overactive Bladder (OAB)
NCT00871494,2011-09-28,May 2009,November 2010,November 2010,2009-03-27,2011-09-28,Interventional,Phase 3,76,Completed,"A Multicenter, Non-Randomized, Open Label Study Of Azithromycin Intravenous Followed By Oral Administration In Japanese Adult Subjects With Pelvic Inflammatory Disease (PID) Requiring Initial Intravenous Therapy",Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan
NCT00873626,2014-11-05,June 2009,August 2011,August 2011,2009-03-31,NA,Interventional,Phase 4,310,Completed,"Randomized Controled Multicentric Trial, of Non Inferiority, Comparing Two Durations of Antibiotherapy (5 Days Versus 10 Days) in COMMUNAUTARY Acute Uncomplicated Pyelonephritis.",Treatment's Duration of Acute Uncomplicated Pyelonephritis
NCT00878098,2019-07-17,"June 1, 2009","July 12, 2019",NA,2009-04-07,NA,Observational,NA,513,Completed,Study of DDT and Loss of Clinically Recognized Pregnancies in South Africa,Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa
NCT00892866,2024-02-21,"February 9, 2009","May 31, 2025","May 31, 2025",2009-05-02,NA,Interventional,Not Applicable,877,"Active, not recruiting","Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)","CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells"
NCT00900653,2009-05-29,May 2009,July 2010,May 2010,2009-05-12,NA,Interventional,Phase 4,142,Unknown status,"Low Dose Estriol With Lactobacilli (Gynoflor) Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized, Open, Parallel-Group Study",Low Dose Estriol With Lactobacilli Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women
NCT00929526,2016-09-09,June 2009,February 2011,February 2011,2009-06-26,2012-02-16,Interventional,Phase 3,752,Completed,Long-term Extension Study of the Efficacy of the 580299 Vaccine in the Prevention of HPV-16 and/or HPV-18 Associated Cervical Intraepithelial Neoplasia (CIN) in Japanese Women Vaccinated in the Primary Vaccination Study NCT00316693,Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
NCT00931190,2009-09-14,February 2001,November 2005,NA,2009-06-30,NA,Observational,NA,195,Completed,"Evaluation of the Use of Human Papillomavirus Persistence for Determination of the Treatment Efficacy Among Women With Cervical Intraepithelial Neoplasia, and for Prediction of Recurrence of Cervical Disease",Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00937547,2012-11-30,November 2009,July 2011,July 2011,2009-07-10,2012-06-06,Observational,NA,329,Completed,"Observational Study for Determine the Presence and Genotypes of HVP Infection in Cervical Intraepithelial Neoplasia Grade II-III (CIN II-III), and Stage I Cervical Epidermoid Carcinoma and Cervical Adenocarcinoma.",Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela
NCT00958295,2015-10-21,March 2009,June 2010,May 2010,2009-08-12,NA,Observational,NA,362,Completed,Epidemiology of Acute Bacterial Uncomplicated Cystitis in General Practice: Description and Prediction by Urine Dipstick Test,Epidemiology of Acute Bacterial Uncomplicated Cystitis in General Practice
NCT00976963,2023-06-02,"September 17, 2009","December 27, 2016","December 27, 2016",2009-09-11,2023-04-01,Interventional,Not Applicable,300,Completed,Single Dose Monurol for Treatment of Acute Cystitis,Single Dose Monurol for Treatment of Acute Cystitis
NCT00978848,2016-05-17,November 2009,April 2010,April 2010,2009-09-16,NA,Observational,NA,305,Completed,Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing: Meeting the Needs of an At-Risk Population,Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing
NCT01021904,2009-11-27,June 2010,December 2014,June 2014,2009-11-27,NA,Interventional,Phase 4,6200,Unknown status,NA,Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
NCT01022346,2016-08-11,August 2009,September 2013,September 2013,2009-11-20,NA,Interventional,Phase 2,206,Completed,"A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study of the Safety and Response Rate of 3 Subcutaneously Administered Doses of 5 X 10^7 PFU RO5217790 in Patients With High Grade Cervical Intraepithelial Neoplasia Grade 2 or 3 Associated With High Risk HPV Infection",A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection
NCT01039051,2009-12-23,June 2009,June 2010,December 2009,2009-12-22,NA,Interventional,Phase 2/Phase 3,1600,Unknown status,Randomized Controlled Trials of Diet and Lifestyle Intervention to Promote Chinese Postpartum Women's Health,Diet and Lifestyle Intervention Study in Postpartum Women in China
NCT01039545,2015-07-08,February 2012,January 2015,December 2014,2009-12-24,NA,Interventional,Phase 4,253,Terminated,"Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting. A Randomized, Double Blind Trial",Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting.
NCT01055106,2011-06-28,January 2010,April 2010,April 2010,2010-01-21,NA,Interventional,Phase 2,255,Completed,"A Multicenter, Randomized, Investigator-Blinded, Phase 2, Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis",Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
NCT01064024,2013-01-24,December 2009,December 2010,December 2010,2010-02-04,NA,Interventional,Phase 3,233,Completed,"A Double Blind, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo as a Urinary Analgesic for Short Term Treatment in Female Subjects Suffering From Pain or Burning When Passing Urine Associated With Uncomplicated Urinary Tract Infections (uUTI)","Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo"
NCT01067131,2012-12-21,March 2010,December 2012,December 2012,2010-02-10,NA,Interventional,Phase 1,48,Completed,A Phase I Randomized Placebo Controlled Study of a Virosome Formulated Anti-Candida Vaccine (PEV7) Administered by the Vaginal (PEV7C) or Intramuscular (PEV7B) Route to Healthy Adult Volunteers,Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection
NCT01095198,2011-07-19,April 2010,January 2013,November 2012,2010-03-29,NA,Interventional,Phase 2/Phase 3,1440,Unknown status,Randomized Controlled Trial of Vaginal Self Sampling for Human Papillomavirus to Increase Cervical Cancer Screening Participation,Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)
NCT01108757,2017-10-17,April 2010,August 2013,August 2013,2010-04-21,2017-01-11,Interventional,Not Applicable,52,Terminated,Prevention of Catheter-Associated Urinary Tract Infections in Patients Undergoing Incontinence and Reconstructive Pelvic Surgery: A Randomized Controlled Trial,Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients
NCT01123603,2015-01-13,May 2010,June 2014,June 2014,2010-05-12,NA,Observational,NA,860,Completed,Lower UTI Evaluation in Women With Uterine Leiomyomata,Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata
NCT01132131,2012-02-01,August 2010,December 2011,December 2011,2010-05-20,NA,Interventional,Phase 4,443,Completed,Use of Standardized Delegation Form in Diagnosing and Treating Acute Cystitis in Primary Care Facilities.,Management of Urinary Tract Infections in Primary Care Facilities.
NCT01142752,2016-08-02,November 2011,May 2015,April 2015,2010-06-07,NA,Observational,NA,71,Completed,"Vaginal, Oral and Systemic Inflammation in Preterm Birth","Vaginal, Oral and Systemic Inflammation in Preterm Birth"
NCT01152528,2010-06-28,July 2010,June 2011,June 2011,2010-06-28,NA,Interventional,Phase 3,248,Unknown status,"VA-SENSE - BACTERIAL VAGINOSIS ONCE A WEEK SCREENING AND TREATMENT TO REDUCE INFECTIVE COMPLICATIONS, ABORTION AND PRETERM DELIVERY IN PREGNANT WOMEN WITH PREVIOUS PRETERM DELIVERY.","Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery"
NCT01160640,2018-07-06,November 2010,August 2015,August 2015,2010-07-08,2016-10-26,Interventional,Phase 2,233,Completed,The Importance of Anti-anaerobic Therapy for Acute PID,The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
NCT01207999,2012-11-21,October 2007,March 2010,March 2010,2010-09-22,NA,Observational,NA,591,Completed,Human Papillomavirus (HPV) Type Distribution in Adult African Women Diagnosed With Invasive Cervical Cancer,Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
NCT01213459,2012-11-21,April 2010,December 2011,December 2011,2010-10-01,NA,Observational,NA,420,Completed,"An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 15 Years of Age, in the Kingdom of Saudi Arabia",Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
NCT01219595,2016-01-28,September 2010,September 2012,September 2012,2010-10-08,NA,Interventional,Not Applicable,65,Completed,Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women,Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
NCT01230814,2014-09-26,April 2011,August 2013,August 2013,2010-10-28,2014-08-14,Interventional,Phase 2,234,Completed,"A Double-Blind, Randomized Trial of Monthly Treatment With Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories Versus Placebo for Preventing Vaginal Infections in HIV-seronegative Women",Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
NCT01231737,2010-10-29,November 2010,February 2012,February 2011,2010-01-14,NA,Interventional,Phase 2,96,Unknown status,Efficacy of Prulifloxacin vs Phosphomycin in the Prophylasy of Urinary Tract Infection,Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)
NCT01235546,2017-06-29,May 2011,December 2015,December 2015,2010-11-04,2017-03-13,Interventional,Not Applicable,2013,Completed,Cesarean Section Optimal Antibiotic Prophylaxis Trial,Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
NCT01236131,2016-08-15,November 2010,August 2015,August 2015,2010-11-04,NA,Observational,NA,480,Completed,Characterization of Novel Organisms in the Genital Tract of Women With PID and Determination of Their Association With Endometritis.,The Role of Novel Organisms in Acute Endometritis
NCT01241110,2010-11-15,January 2010,September 2010,August 2010,2010-11-15,NA,Interventional,Phase 4,100,Completed,Phase 4 Study of Azitromicin in the Treatment of PID,To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
NCT01281319,2011-01-20,January 2011,December 2012,December 2011,2011-01-20,NA,Observational,NA,300,Unknown status,Evaluation of a Diagnostic Kit for the Detection of Serum Antibodies Anti Genital Mycoplasma in High Risk Pregnant Women,Evaluation of a Serology Diagnostic Kit for the Detection of Genital Mycoplasma in Pregnancy
NCT01290393,2018-07-25,"September 26, 2011","December 20, 2012","December 20, 2012",2011-02-03,NA,Observational,NA,2,Terminated,Post-marketing Safety Study to Assess the Risk of Spontaneous Abortion Following Administration of CERVARIX in the United States and Canada,Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada
NCT01299259,2014-10-27,February 2011,October 2014,October 2014,2010-11-30,NA,Interventional,Not Applicable,95,Completed,Improving Primary Care Follow-up for Adolescents With PID: A Randomized Controlled Trial Using Text Message Reminders,Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
NCT01322971,2021-12-10,February 2011,June 2012,June 2012,2011-03-23,2016-10-26,Interventional,Not Applicable,2,Terminated,"Pregnancy Outcomes Following Preconception Treatment of Asymptomatic Bacterial Vaginosis in an Infertility Population: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.",Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
NCT01337791,2011-04-18,August 2008,December 2009,December 2009,2011-04-15,NA,Interventional,Phase 4,88,Completed,NA,"Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels"
NCT01346774,2015-05-26,June 2011,October 2013,May 2013,2011-04-29,2015-04-28,Interventional,Phase 2,200,Completed,Phase II Efficacy of Cranberry Powder in Preventing Catheter-associated Urinary Tract Infection Post Elective Gynecological Surgery,Preventing Urinary Tract Infection Post-Surgery
NCT01347632,2017-11-20,April 2011,December 2011,December 2011,2011-04-15,2013-11-01,Interventional,Not Applicable,35,Completed,Prospective Evaluation of the Impact of Bacterial Vaginosis and Its Treatment on Mucosal Susceptibility to HIV-1 Infection and Endpoints of Cervico-Vaginal Safety,Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue
NCT01357369,2016-04-19,January 2011,December 2011,December 2011,2011-05-10,NA,Observational,NA,20,Completed,Pharmacokinetics and Placental Transfer of Ondansetron and Cefazolin: A Preliminary Analysis,Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates
NCT01359046,2019-04-25,July 2011,"March 9, 2018","March 2, 2018",2011-05-20,2019-04-04,Interventional,Not Applicable,288,Completed,Randomized Control Trial of Silver-alloy Impregnated Suprapubic Catheters in Urogynecology Patients,Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology
NCT01361048,2017-12-19,December 2011,January 2013,August 2012,2011-05-24,2013-11-18,Interventional,Phase 2,40,Completed,Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis,Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
NCT01375439,2015-06-19,August 2011,May 2013,December 2012,2011-03-23,NA,Interventional,Not Applicable,280,Completed,Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous Pregnancy and Submitted to Active Search of Genital Infection,Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous Pregnancy
NCT01406587,2011-10-18,July 2011,October 2011,October 2011,2011-07-26,NA,Interventional,Phase 2,261,Completed,"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of 50 mg, 100 mg and 200 mg PP4001 Twice Daily for the Treatment of Burning During Urination, Pain, and Urination Frequency Associated With Uncomplicated Urinary Tract Infection",Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection
NCT01450800,2016-12-23,August 2011,September 2013,March 2013,2011-10-10,2013-09-30,Interventional,Phase 4,163,Completed,Antibiotic Prophylaxis for Urinary Tract Infection in Patients Requiring Catheterization After Urogynecologic Surgery,Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
NCT01456962,2017-05-08,October 2011,August 2013,August 2013,2011-10-06,2015-05-18,Observational,NA,36,Completed,Influence of Raltegravir-Containing Antiretroviral Therapy (ART) on Immune Reconstitution and Activation in the Female Genital Tract,Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
NCT01478620,2019-02-05,October 2011,August 2012,May 2012,2011-11-21,2014-08-27,Interventional,Phase 3,125,Completed,"An Open-label, Non-randomized, Multicenter, Interventional Study to Investigate the Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)",Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)
NCT01488955,2014-08-07,February 2012,July 2014,February 2014,2011-12-07,NA,Interventional,Phase 4,494,Completed,Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - a Comparative Effectiveness Study in General Practice (ICUTI),Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI
NCT01507974,2020-05-17,"January 16, 2012","January 1, 2015","July 1, 2014",2012-01-04,NA,Interventional,Not Applicable,220,Completed,The Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections,Examination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections
NCT01525498,2013-10-15,August 2011,April 2013,April 2013,2012-01-19,NA,Observational,NA,0,Withdrawn,Urinary Bladder Catheterization Following Sacrocolpopexy,Foley Catheterization Following Sacrocolpopexy
NCT01539668,2014-02-25,March 2012,February 2014,December 2012,2012-01-23,NA,Observational,NA,5079,Completed,CareHPV - Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas,Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas
NCT01550783,2020-07-29,March 2012,"November 16, 2017","November 16, 2017",2012-02-17,NA,Interventional,Not Applicable,1335,Completed,"Cytology vs. at Home HPV Screening for Detection of CIN 2,3,CIS",Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
NCT01588301,2014-09-11,February 2012,December 2012,December 2012,2012-03-12,NA,Interventional,Early Phase 1,5998,Completed,Attitudes to Different Strategies Among Women Not Attending Cervical Cancer Screening: Further Invitation by Mail or Kit for Self-collected Vaginal Sample,Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01590017,2022-07-21,"April 1, 2014","April 20, 2017","April 20, 2017",2012-05-01,2019-07-18,Interventional,Phase 2,41,Completed,"Feasibility Study of Safety, Toxicity, and Compliance of Concomitant Chemoradiotherapy for HIV-Associated Locally-Advanced Cervical Cancer",Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer
NCT01593124,2015-03-30,May 2012,April 2013,April 2013,2012-03-09,NA,Interventional,Phase 2,20,Completed,Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation,Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
NCT01597804,2020-07-21,April 2011,April 2016,February 2014,2012-05-10,NA,Interventional,Not Applicable,435,Completed,"A ""Bathing Bundle"" Regimen to Reduce the Risk of Gynecological Surgical Site Infection",Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery
NCT01637870,2018-03-19,August 2012,February 2013,February 2013,2012-07-06,2015-05-26,Interventional,Not Applicable,110,Completed,Negative Pressure Wound Therapy to Prevent Post Operative Wound Complications Following Cesarean Delivery in Women at High Risk for Wound Complications,Negative Pressure Wound Therapy After Cesarean Delivery
NCT01640379,2020-05-14,July 2012,April 2017,March 2017,2012-07-11,2017-12-18,Interventional,Not Applicable,286,Completed,Technology Enhanced Community Health Nursing (TECH-N) to Prevent Recurrent Sexually Transmitted Infections After Pelvic Inflammatory Disease,Technology Enhanced Community Health Nursing (TECH-N) Study
NCT01650051,2014-06-25,February 2012,February 2014,February 2013,2012-07-19,NA,Interventional,Phase 3,424,Completed,"A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)","Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)"
NCT01653392,2024-03-14,July 2012,February 2020,February 2020,2012-07-16,NA,Observational,NA,98,Completed,BioThrax® (Anthrax) Vaccine in Pregnancy Registry,BioThrax® (Anthrax) Vaccine in Pregnancy Registry
NCT01663181,2022-04-08,May 2009,April 2010,February 2010,2012-08-05,NA,Observational,NA,109,Completed,Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study,Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study
NCT01687114,2014-12-10,September 2012,April 2014,March 2013,2012-09-13,2014-11-13,Interventional,Not Applicable,5,Completed,Urinary Proanthocyanidin (PAC) A2 as a Biomarker of Compliance to Intake of Cranberry Products - A Pilot Study,Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products
NCT01691430,2020-03-04,August 2012,October 2015,October 2015,2012-08-09,2017-02-14,Interventional,Phase 3,185,Completed,"A Randomized, Controlled Trial of Cranberry Capsules for UTI Prevention in Nursing Home Residents",A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents
NCT01693783,2022-10-17,"December 3, 2012","November 24, 2021","March 18, 2021",2012-09-21,2022-06-28,Interventional,Phase 2,42,Completed,A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies,Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
NCT01735006,2020-02-21,"November 22, 2012","October 18, 2019","August 1, 2019",2012-11-18,NA,Interventional,Phase 3,7372,Completed,"A Phase III Multicenter, Randomized, Double-Blind, Placebo(Hepatitis E Vaccine)Controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant(E.Coli)Human Papillomavirus Bivalent Vaccine in Healthy Women",Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine
NCT01776021,2015-04-24,January 2013,April 2015,December 2014,2013-01-23,NA,Interventional,Not Applicable,330,Completed,"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections",Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
NCT01779193,2015-04-26,June 2012,July 2015,July 2015,2013-01-28,NA,Interventional,Phase 4,200,Unknown status,"A Double-blind,Randomized,Parallel,Placebo-controlled Study of Probiotics Capsule as Supplemental Therapy for Group B Streptococci Infection and Vaginitis During Pregnancy",Probiotics Capsule as Supplemental Therapy for Group B Streptococci Infection and Vaginitis During Pregnancy
NCT01792973,2021-10-20,February 2012,December 2016,December 2016,2013-02-11,NA,Observational,NA,829,Completed,HPV Infection and Cervical Lesions in HIV Infected Women in Thailand,HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study
NCT01799356,2013-08-27,June 2010,March 2013,March 2013,2013-02-16,NA,Interventional,Phase 4,1303,Completed,NA,Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
NCT01800799,2017-02-16,February 2013,December 2014,December 2014,2013-02-19,NA,Interventional,Not Applicable,37,Completed,Use of Urinary Nerve Growth Factor as A Biomarker to Determine Complete Resolution of Bladder Inflammation After Acute Bacterial Cystitis in Women,Urinary NGF as A Biomarker for Acute Bacterial Cystitis
NCT01808755,2014-04-25,January 2012,October 2012,October 2012,2013-03-07,2013-04-01,Interventional,Phase 3,60,Completed,Recurrent Urinary Tract Infections in Adult Women: a Pilot Study With Oral D Mannose,D Mannose in Recurrent Urinary Tract Infections
NCT01812889,2014-05-15,April 2013,May 2014,January 2014,2013-03-14,NA,Interventional,Phase 1,26,Completed,"A Two Part Randomized, Open-Label Phase I Safety and Pharmacokinetic Evaluation of Gel and Ovule Formulations of TOL-463 (Intravaginal Therapy) in 18-45 Year Old Healthy Female Subjects and Women With Vaginitis",Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463
NCT01818180,2013-03-21,May 2010,NA,September 2012,2013-03-19,NA,Interventional,Not Applicable,11,Terminated,Effect of URELL(Cranberry Vaccinium Macrocarpon)Consumption on the Prevalence of Recurrent Urinary Tract Infection and Asymptomatic Bacteriuria During Pregnancy.,Urell and Pregnancy
NCT01820793,2018-01-11,May 2013,November 2015,July 2015,2013-02-19,NA,Interventional,Not Applicable,9,Terminated,Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli.,Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
NCT01832480,2019-01-22,"October 6, 2014","June 5, 2017","June 5, 2017",2013-04-04,2018-09-10,Interventional,Phase 3,623,Completed,Trichomonas Vaginalis Repeat Infections Among HIV Negative Women,Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
NCT01842100,2013-04-24,September 1999,February 2006,February 2006,2013-04-21,NA,Interventional,Not Applicable,2193,Completed,To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy,To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
NCT01843166,2018-11-02,July 2012,December 2016,December 2016,2012-07-08,NA,Interventional,Not Applicable,150,Completed,Use of Vaginal Estrogen With Pessary Treatment of Pelvic Organ Prolapse and Urinary Incontinence,Vaginal Estrogen With Pessary Treatment
NCT01867164,2013-11-01,December 2007,December 2008,December 2008,2013-05-29,2013-07-12,Interventional,Phase 3,160,Completed,"A Prospective, Open-Label, Comparative, Parallel Double-Arm, Multicentric Clinical Study to Evaluate the Efficacy of an Ovule With Triple Active Agents (Terconazole, Clindamycin, Fluocinolone) Administered Once Per Day for Three Days Versus an Ovule With Triple Active Agents (Metronidazole, Nystatin, Fluocinolone) Administered Once Per Day for Ten Days to Treat Secondary Vulvar/Vaginal Symptoms of Vaginitis/Infectious Vaginosis (Bacterial and/or Mycotic and/or Parasitic)","A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis"
NCT01874158,2016-12-16,November 2012,April 2014,April 2014,2013-06-06,NA,Observational,NA,99,Completed,DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women,DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women
NCT01881165,2014-12-12,September 2014,March 2016,December 2015,2013-06-17,NA,Interventional,Phase 4,0,Withdrawn,"A Randomized, Double-blind, Placebo Controlled Trial Evaluating the Effectiveness of a Cranberry Concentrate in Preventing Recurrent Urinary Tract Infections in Adult Women",Cranberry on Urinary Tract Infections
NCT01891331,2018-07-05,August 2013,December 2014,December 2014,2013-06-17,2018-06-06,Interventional,Phase 2,55,Completed,"A Phase 2A, Randomized, Double-Blind, Dose Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets Compared to Fluconazole in the Treatment of Patients With Moderate to Severe Acute Vulvovaginal Candidiasis",A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)
NCT01905462,2013-09-26,November 2012,August 2013,August 2013,2013-07-18,NA,Observational,NA,1046,Completed,Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix in the United Kingdom,Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK
NCT01915251,2019-09-11,"July 30, 2013","September 10, 2019","August 15, 2019",2013-07-30,NA,Observational,NA,13,Terminated,Microbiomic and Immunologic Profiling of Women With Antibiotic Induced Vaginal Candidiasis,Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
NCT01958073,2020-08-26,October 2013,December 2017,December 2017,2013-03-27,2018-12-30,Interventional,Phase 4,35,Completed,Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial,Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
NCT01966653,2017-05-01,October 2013,August 2017,May 2017,2013-10-10,NA,Interventional,Phase 4,600,Unknown status,Randomised Clinical Trial Comparing Fosfomycin vs. Nitrofurantoin for Treatment of Uncomplicated Lower Urinary Tract Infection in Female Adults at Increased Risk of Antibiotic-resistant Bacterial Infection,Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women
NCT01988168,2017-05-11,February 2014,December 2019,December 2019,2013-10-31,NA,Interventional,Not Applicable,60,Unknown status,Closure of Skin in ChorioAmnionitis Research Pilot Study,Closure of Skin in ChorioAmnionitis Research Pilot Study
NCT02016118,2014-02-11,January 2014,December 2014,March 2014,2013-10-07,NA,Observational,NA,500,Unknown status,INTRAVESICAL ADMINISTRATION OF COMBINED HYALURONIC ACID (HA) AND CHONDROITIN SULPHATE (CS) vs. STANDARD OF CARE FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS (RUTIs),Retrospective Analysis of Ialuril vs. Standard of Care in Recurrent Urinary Tract Infections
NCT02074852,2014-03-01,November 2012,NA,December 2013,2014-02-24,NA,Observational,NA,300,Completed,NA,Comparison of Immediate Versus Delayed Removal of Urinary Catheter Following Elective Cesarean Section
NCT02087735,2016-10-07,January 2014,March 2014,March 2014,2014-03-12,NA,Interventional,Phase 1,15,Completed,Measurement of Urinary Catabolites of the Proanthocyanidines (PACs) in Healthy Young Women as Biomarkers of Consumption of Cranberry Extracts.,Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts
NCT02094703,2014-03-19,April 2013,December 2014,November 2014,2014-03-10,NA,Interventional,Phase 4,126,Unknown status,The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Symptomatic Non-complicated Urinary Tract Infection in Females,The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females
NCT02124252,2019-04-09,January 2016,March 2019,October 2016,2014-04-24,NA,Interventional,Not Applicable,7200,Completed,Evaluation of a Community-Driven Cervical Cancer Prevention Strategy in Western Kenya,Community-Driven Cervical Cancer Prevention in Western Kenya
NCT02186145,2015-04-08,January 2016,January 2017,January 2017,2014-07-07,NA,Interventional,Phase 3,160,Unknown status,"Single Blind Randomized Study of Efficacy and Safety of Vaginal Cream With Association of Metronidazole, Nystatin and Dexamethasone in the Treatment of Bacterial and Fungal Vaginal Infections","Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections"
NCT02189291,2019-03-13,July 2014,"December 31, 2018","July 1, 2018",2014-07-03,NA,Interventional,Not Applicable,72,Completed,When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?,Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
NCT02203942,2016-01-26,July 2014,June 2015,June 2015,2014-07-25,NA,Observational,NA,300,Completed,Comparing NAAT Testing to Standard Methods in Diagnosis of Vaginal Infections in the General Gynecology and Vulvovaginal Referral Offices.,Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis
NCT02216253,2015-08-24,October 2014,NA,August 2015,2014-08-09,NA,Interventional,Not Applicable,150,Completed,"L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection: a Double-blind Randomized Controlled Trial.","L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection."
NCT02246270,2023-12-12,"November 28, 2017",December 2024,December 2024,2014-09-15,NA,Interventional,Phase 1/Phase 2,30,Recruiting,Recurrent Urinary Tract Infections and Heparin: a Double-blind Randomized Trial (RUTIH Trial),Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
NCT02267382,2019-10-07,"February 10, 2015","November 9, 2016","November 9, 2016",2014-10-08,2019-09-10,Interventional,Phase 2,254,Completed,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets in the Treatment of Patients With Recurrent Vulvovaginal Candidiasis",A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT02289794,2016-02-10,January 2014,September 2015,July 2015,2014-11-03,NA,Interventional,Phase 1,194,Completed,Evaluation of a Candidate Vaccine Against Uropathogenic Escherichia Coli in Women With a Clinical History of Recurrent Urinary Tract Infection,Vaccine Against Escherichia Coli Infection
NCT02304770,2019-06-11,January 2015,January 2017,January 2017,2014-11-23,NA,Interventional,Phase 2,73,Completed,A Pilot Study of Aminolaevulinic Acid (ALA) Photodynamic Therapy (PDT) in Patients With Cervical Persistent High Risk HPV Infection or Cervical Intraepithelial Neoplasia,Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia
NCT02309346,2018-08-27,"December 31, 2014",December 2019,November 2019,2014-12-03,NA,Interventional,Phase 4,190,Unknown status,A Randomized Clinical Trial Between Clindamycin Once and Thrice a Day in Septic Abortion.,Clindamycin Once a Day in Septic Abortion
NCT02323087,2016-05-02,March 2015,May 2016,May 2016,2014-12-11,NA,Interventional,Not Applicable,377,Completed,"Reducing Antibiotic Resistance: Improved Diagnostics and Treatment for Uncomplicated Urinary Tract Infection in General Practice, Denmark",Point of Care Susceptibility Testing in Primary Care
NCT02346227,2018-10-11,January 2015,August 2018,August 2018,2014-11-08,NA,Interventional,Phase 3,327,Completed,"Efficiency of AV2 Antiviral Drug in the Treatment of Human Papillomavirus-associated Precancerous Lesions of the Uterine Cervix: a Randomized Clinical Trial in Kinshasa, Democratic Republic of the Congo",Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
NCT02358993,2022-02-03,December 2014,"September 30, 2020","September 30, 2020",2015-02-03,2021-09-24,Interventional,Not Applicable,201,Completed,The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection,Short-course Methenamine Hippurate for Prevention of Post-operative UTI
NCT02366676,2019-11-28,January 2014,"October 30, 2019",January 2018,2015-02-12,NA,Interventional,Phase 4,105,Completed,"Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract: a Multicenter, Prospective Study",Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract
NCT02402907,2020-10-16,April 2015,"October 11, 2019","October 11, 2019",2015-03-25,2020-10-16,Interventional,Not Applicable,1356,Completed,A Randomized Trial to Determine if a Pre-operative Wash With a Chlorhexidine Cloth Reduces Infectious Morbidity in Patients Undergoing Cesarean Section,STRIPES Study: Study To Reduce Infection Post cEsarean Section
NCT02439632,2015-07-15,February 2014,July 2015,March 2015,2014-06-04,NA,Interventional,Phase 3,216,Completed,"A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control","A Multi-center, Randomized, Double-blind, Double-dummy Clinical Study to Evaluate the Safety and Efficacy of Prulifloxacin Film-coated Tablet for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection With Levofloxacin Hydrochloride Tablet as Active Control"
NCT02444975,2016-09-05,December 2013,July 2016,July 2016,2015-04-29,NA,Interventional,Not Applicable,140,Completed,The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST,The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST
NCT02454309,2016-05-30,July 2015,March 2017,December 2016,2015-05-22,NA,Interventional,Phase 4,150,Unknown status,"A Randomised, Double-blind, Placebo Controlled Trial Evaluating the Effectiveness of a Cranberry Concentrate (CranrichTM) in Preventing Recurrent Urinary Tract Infections in Adult Women",Cranberry for the Prevention of Urinary Tract Infections
NCT02509403,2020-03-30,January 2020,January 2020,January 2020,2015-07-24,NA,Interventional,Phase 1,0,Withdrawn,An Open-label Trial to Evaluate the Safety of an Essential Oil Infused Perineal Towel - WIPEAWAY,An Open-label Trial to Evaluate the Safety of an Essential Oil Infused Perineal Towel
NCT02515656,2018-08-13,September 2015,August 2016,August 2016,2015-07-29,2017-09-21,Interventional,Phase 3,661,Completed,"Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis International, Multicentre, Randomised, Double-blind, Parallel Group Study, Comparative Versus Miconazole",Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis
NCT02527941,2016-02-09,August 2015,November 2015,November 2015,2015-08-14,NA,Interventional,Phase 1,50,Completed,Effect of Bacterial Vaginosis and Its Treatment on HIV Susceptibility and Female Genital Immunology,Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology
NCT02536872,2016-10-13,October 2015,October 2016,September 2016,2015-08-24,NA,Observational,NA,25,Completed,An Observational Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder,A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder
NCT02543827,2021-02-17,November 2015,December 2020,"November 4, 2020",2015-08-17,NA,Interventional,Phase 3,240,Completed,"Prospective Randomized, Double-blind, Parallel-controlled Versus Placebo in a Polyvalent Sublingual Bacterial Vaccine to 3 Months and 6 Months in Women With RUTI for the Immunomodulatory Efficacy Evaluation, Safety and Clinical Impact",Evaluation of the Efficacy and Safety of MV140
NCT02562508,2018-08-15,"December 5, 2015","August 12, 2016","August 12, 2016",2015-09-14,NA,Interventional,Phase 3,979,Completed,"Immunogenicity and Safety Study of a Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Female Subjects Aged 9 to 17 Years",A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
NCT02567812,2019-04-01,October 2015,September 2024,September 2024,2015-10-01,NA,Observational [Patient Registry],NA,200,Recruiting,Prospective Data Collection of Patients With Pelvic Inflammatory Disease,Database of Pelvic Inflammatory Disease
NCT02572895,2016-09-07,August 2015,December 2017,June 2017,2015-10-08,NA,Interventional,Phase 1,140,Unknown status,Recurrent Urinary Tract Infection Prevention With Biologic Cranberry Extract Intake Standardized in Proanthocyanidins: A Double-blind Clinical Trial,Cranberry Extract and Urinary Infection Prevention: a Clinical Trial
NCT02585115,2016-10-05,October 2015,July 2016,July 2016,2015-10-05,NA,Observational,NA,117,Completed,"Is a First Void Urine Sample as Accurate as a Midstream Urine Sample in Diagnosing Urinary Tract Infections With a Point-Of-Care-Test Method in Adult, Symptomatic, Non-pregnant Women in General Practice?",Diagnostic Accuracy of Point of Care Test of First Voided Urine Compared to Midstream Voided Urine in Primary Care
NCT02631863,2019-07-05,"March 22, 2016","November 24, 2018","November 24, 2018",2015-12-12,NA,Interventional,Phase 2,60,Completed,A Pilot Study of Photodynamic Therapy (PDT) Using Aminolaevulinic Acid (ALA) in Patients With HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1),Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
NCT02637986,2022-11-07,"November 7, 2022","November 7, 2022","November 7, 2022",2015-12-16,NA,Interventional,Not Applicable,0,Withdrawn,The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy - a Prospective Randomized Double Blind Placebo-control Study,The Efficacy of Orally Administrated Probiotic Formula in Preventing a Recurrence of a Urinary Tract Infection During Pregnancy
NCT02639520,2017-07-26,December 2015,"June 29, 2017",June 2017,2015-12-11,NA,Interventional,Phase 3,659,Completed,"A Double-blind, Controlled, Parallel-group, Randomized, Multicenter Clinical Trial to Assess the Efficacy and Safety of a Herbal Drug Containing Centaury, Lovage Root and Rosemary Leaf (CLR) in Comparison to Fosfomycin Trometamol for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections (uUTIs) in Women",Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs
NCT02653118,2024-04-12,"January 22, 2016","January 1, 2040","January 1, 2040",2016-01-08,NA,Observational,NA,4453,"Active, not recruiting","A Registry-Based Extension of Protocol V503-001 in Countries With Centralized Cervical Cancer Screening Infrastructures to Evaluate the Long-Term Effectiveness, Immunogenicity, and Safety of Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine as Administered to 16- to 26- Year-Old Women",Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
NCT02673216,2021-05-06,September 2015,December 2023,December 2020,2016-01-27,NA,Observational,NA,2200,Unknown status,Infection and Adverse Pregnancy Outcome,Infection and Adverse Pregnancy Outcome
NCT02693483,2016-02-25,April 2015,October 2016,June 2016,2016-02-15,NA,Interventional,Phase 4,306,Unknown status,Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis,Preoperative Vaginal Cleansing With Povidone Iodine and the Risk of Post Cesarean Endometritis
NCT02702297,2018-11-12,"January 7, 2016","November 10, 2018","February 28, 2018",2016-02-22,NA,Observational,NA,57,Completed,Multimodales Monitoring Des Fetalen Inflammationsrisikos Bei frühem Vorzeitigen Blasensprung (PPROM),Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
NCT02705495,2022-08-04,May 2015,June 2022,December 2021,2016-02-01,NA,Interventional,Not Applicable,136,Completed,Segmental and Ear Acupuncture for Prevention of Recurrent Urinary Tract Infections(SARUTI Study): a Multicenter Randomized Controlled Trial,Acupuncture for Prevention of Recurrent Urinary Tract Infections.
NCT02733068,2022-12-16,"November 2, 2014","January 16, 2020","July 30, 2019",2016-02-19,NA,Interventional,Phase 3,12000,Completed,"A Phase III Double Blinded, Randomized Controlled Study to Evaluate Efficacy of Protection Against HPV-16 and 18 Related Diseases, Immunogenicity and Safety of HPV-16/18 Vaccine in Healthy Females Aged 18-30 Years",A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
NCT02733432,2020-08-21,"June 8, 2016","December 23, 2016","November 23, 2016",2016-03-28,NA,Interventional,Phase 2,126,Completed,"A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis",RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
NCT02740777,2023-04-12,February 2016,July 2019,November 2016,2016-04-05,NA,Interventional,Phase 2,900,Completed,"Immunogenicity Study of a 2-dose Immunization Schedule of Recombinant Human Papillomavirus Virus-like Particle Vaccine (Type 16 and 18 L1 Proteins, Yeast) in Adolescent Females Aged 9 to 14 Years",Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
NCT02742636,2017-08-22,"May 31, 2016","June 21, 2017","June 21, 2017",2016-04-01,NA,Interventional,Not Applicable,162,Completed,When is the Best Moment to Remove the Urinary Catheter After Laparoscopic Hysterectomy: MUCH Study.,When is the Best Moment to Remove the Urinary Catheter After Laparoscopic Hysterectomy?
NCT02746588,2022-03-14,"February 1, 2016","January 1, 2019","January 1, 2019",2016-04-18,NA,Observational,NA,100,Completed,Description of the Uterine Cavity in Patients With Recurrent Miscarriages,Description of the Uterine Cavity in Patients With Recurrent Miscarriages
NCT02751073,2018-08-14,February 2016,"July 30, 2018","May 31, 2017",2016-02-22,NA,Observational,NA,25,Completed,Evaluation of Vaginal and Urinary Microbiome Markers as Predictors of Post-Surgical Urinary Tract Infection,Evaluation of the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After Hysterectomy
NCT02755012,2016-04-26,June 2012,November 2013,November 2013,2016-04-19,NA,Observational,NA,271,Completed,"Reducing Maternal Stress Due to Infection, Malnutrition and Psychosocial Conditions of Poverty: A New Paradigm for Tackling Infant Stunting",Impact of Maternal Stress on Infant Stunting
NCT02787486,2019-08-19,October 2015,September 2018,September 2018,2016-05-26,NA,Observational,NA,760,Completed,"A Clinical Study to Evaluate the Relative Clinical Sensitivity, Specificity, and Performance of the a Laboratory Developed Test as a Screening Test for Fetal Chromosomal Aneuploidy, Infectious and Other Diseases, and RhD Genotyping in the General Population of Pregnant Women",Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
NCT02795845,2021-08-02,November 2016,August 2021,July 2021,2016-06-07,NA,Interventional,Not Applicable,157,Completed,"Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study","Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study"
NCT02811367,2016-10-14,June 2016,September 2016,September 2016,2016-06-20,NA,Interventional,Not Applicable,117,Completed,The HPV Self-test as a Test of Cure in the Follow-up of HPV-positive Women in Madagascar,The HPV Self-test as a Test of Cure in Madagascar
NCT02812914,2017-10-25,April 2016,"June 19, 2017","June 19, 2017",2016-06-03,NA,Interventional,Not Applicable,50,Completed,NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health,NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health
NCT02830321,2016-07-11,March 2015,December 2015,December 2015,2016-07-03,NA,Observational,NA,90,Completed,Study to Explore the Association Between Hyperemesis Gravidarum in Pregnant Women and Helicobacter Pylori Infection by Using H.P. Stool Antigen Test to Diagnose H Pylori Infection,The Association of Helicobacter Pylori in the Pathogenesis of Hyperemesis Gravidarum in Pregnant Women
NCT02840825,2022-07-26,"March 8, 2016","September 29, 2021","September 29, 2021",2016-07-19,NA,Observational,NA,2,Terminated,Biochip for HCMV Detection in Breast Milk From Lactating Women of Preterm Infants Less Than 33 Weeks,Biochip for HCMV Detection in Breast Milk
NCT02845284,2019-05-15,"March 30, 2016","December 30, 2017","December 1, 2017",2016-07-20,NA,Interventional,Not Applicable,486,Completed,Enhanced HIV/Sexually Transmitted Infections and Pregnancy Prevention Study to Improve Adolescent Reproductive Health Services in Uganda,'HI-4-TU' Study: Health Improvement for Teen Ugandans Study
NCT02859493,2018-06-11,August 2016,NA,March 2017,2016-08-04,NA,Interventional,Not Applicable,80,Terminated,Evaluation of the Effect of Saccharomyces Cerevisiae on the Improvement of the Conventional Treatment for Vulvo-vaginal Infection to Candida Spp (Local Administration),Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis
NCT02860845,2019-11-05,"July 12, 2016","November 30, 2017","October 16, 2017",2016-07-19,2019-08-19,Interventional,Phase 4,48,Completed,"Multicenter Pilot Study to Compare the Efficacy of a Combination of Vaginal Capsules With Acid Boric, L.Gasseri and L.Rhamnosus Versus the Reference Medication in Patients With Vaginal Candidiasis or Bacterial Vaginosis",Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections
NCT02869165,2021-05-13,January 2017,"December 31, 2019","June 30, 2018",2016-07-31,NA,Interventional,Phase 4,110,Completed,The Effects of Vaginal Estrogen and a Nonhormonal Alternative on the Vaginal and Urinary Microbiome in Women With Genitourinary Syndrome of Menopause: A Randomized Controlled Trial,Vaginal and Urinary Microbiome Trial
NCT02882360,2016-08-24,October 2016,December 2018,January 2018,2016-05-12,NA,Interventional,Phase 4,40,Unknown status,The Use of Antimicrobial Gauze in Pregnant Women Undergoing C-section With BMI >40 to Decrease Wound Complications by 6 Weeks postpartum--a Small Feasibility Study,Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum
NCT02888197,2018-02-28,"August 16, 2016","March 15, 2017","March 15, 2017",2016-08-30,NA,Observational,NA,32,Completed,"A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis",Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
NCT02905890,2020-03-10,"October 2, 2017","December 20, 2019","December 20, 2019",2016-09-09,NA,Interventional,Phase 4,250,Completed,"Hormonal Contraception and Bacterial Vaginosis (HCBV): The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis Among Women at High Risk for HIV Infection in Kampala, Uganda",The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis
NCT02946346,2020-10-13,"November 11, 2016","September 29, 2020","September 29, 2020",2016-08-22,NA,Interventional,Not Applicable,190,Terminated,KINETICS AND ECOLOGY OF HUMAN PAPILLOMAVIRUS (HPV) GENITAL INFECTIONS IN YOUNG WOMEN,Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women
NCT02971007,2018-10-04,November 2016,May 2017,May 2017,2016-11-10,2018-09-07,Interventional,Phase 2,137,Completed,"A Multi-Center Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) Compared With Oral Fluconazole in the Treatment of Moderate to Severe Vulvovaginal Candidiasis (VVC)",Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
NCT02972151,2016-11-21,November 2016,December 2018,December 2018,2016-11-17,NA,Interventional,Phase 2,175,Unknown status,Clinical Promotion Research of Complex Treatment With TCM to Diagnosis and Treatment on Different Syndrome Types of Pelvic Inflammatory Disease Sequelae,Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
NCT02986802,2021-08-23,"March 14, 2017","February 28, 2021","October 15, 2019",2016-12-06,2021-06-28,Observational,NA,89132,Completed,Comparative Effectiveness of Treatment Options for Genital Herpes Infection in Pregnant Women to Reduce Adverse Pregnancy Outcomes,Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes
NCT02993185,2021-05-21,"October 1, 2016","December 31, 2020","December 31, 2020",2016-11-28,NA,Interventional,Not Applicable,808,Completed,An Integrated Group-Individual Curriculum to Prevent Teen Pregnancy,"Making Healthy Decisions: A Trial Evaluating the ""Your Move"" Teen Pregnancy-prevention Intervention"
NCT02996981,2022-10-19,"November 21, 2016",December 2017,"July 14, 2017",2016-12-15,2022-10-19,Observational,NA,167,Completed,Do Cranberry Juice Capsules Reduce the Risk of Urinary Tract Infections in Patients With Indwelling Urinary Catheters Following Urogynecologic Surgery?,Cranberry Effect on Urinary Tract Infections
NCT03005353,2020-06-07,"March 1, 2018","January 31, 2020","October 31, 2019",2016-12-23,NA,Interventional,Phase 2/Phase 3,100,Completed,Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.,Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.
NCT03008421,2020-12-05,"June 1, 2018","December 16, 2019","December 16, 2019",2016-12-27,NA,Interventional,Not Applicable,1058,Completed,Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy: A Randomized Placebo-controlled Double-blinded Trial,Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy
NCT03009968,2018-03-15,"March 17, 2017","February 1, 2018","January 1, 2018",2017-01-02,NA,Interventional,Not Applicable,150,Completed,Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial,Reducing Postoperative Catheterization
NCT03019172,2017-11-27,"March 5, 2017","September 30, 2017","July 30, 2017",2017-01-10,NA,Interventional,Not Applicable,40,Completed,"Safety, and Effectiveness of Lactobacillus Reuteri for the Treatment of Urinary Tract Infections in Women: A Pilot Randomized Clinical Trial (RCT)",Clinical Trial of L. Reuteri in Urinary Tract Infections in Non Pregnant Women
NCT03019874,2021-02-15,January 2017,February 2019,December 2018,2017-01-02,NA,Observational,NA,23,Completed,Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections,Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections
NCT03032003,2017-01-23,"February 15, 2017","May 31, 2018","March 31, 2018",2017-01-13,NA,Interventional,Not Applicable,160,Unknown status,"Prophylactic Use of Cranberries in Recurrent Bacterial Cystitis in Women: A Randomized, Comparative, Study.",Prophylactic Use of Cranberries in Recurrent Bacterial Cystitis in Women
NCT03042273,2020-03-16,"May 15, 2017","December 31, 2019","December 31, 2019",2017-02-01,NA,Interventional,Phase 2,150,Completed,"A Randomised, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of High Strength Cranberry (Pacran®) in Women With Recurrent Urinary Tract Infections (Cystitis)",High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection
NCT03045809,2019-07-31,"July 5, 2016","August 6, 2018","March 14, 2017",2017-02-02,2019-04-26,Observational,NA,705,Completed,Improving HIV Prevention and Sexual and Reproductive Health Care in High Risk Women in Rwanda Using Lessons Learnt From Previous Rinda Ubuzima Projects,Women's Improvement of Sexual Health (WISH) Demonstration Project
NCT03050515,2020-06-17,"February 5, 2018","February 23, 2020","June 30, 2019",2017-02-03,NA,Interventional,Early Phase 1,12,Completed,Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract,Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections
NCT03055130,2017-02-15,July 2015,July 2017,May 2017,2017-02-08,NA,Observational [Patient Registry],NA,160,Unknown status,HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study,HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study
NCT03064789,2021-02-10,"December 29, 2016","June 30, 2019","March 30, 2019",2017-02-10,NA,Observational,NA,43,Completed,Estudio epidemiológico de la evolución clínica y microbiológica en Pacientes Tratadas Por un Episodio Agudo de Candidiasis Vulvovaginal,Epidemiological Study in Subjects With Vulvovaginal Candidiases
NCT03077711,2020-01-10,June 2016,"June 21, 2019","June 21, 2019",2017-02-27,2019-12-12,Interventional,Phase 4,92,Completed,Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs,Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs
NCT03080389,2018-08-30,"July 1, 2017","August 1, 2018","August 1, 2018",2016-12-20,NA,Observational,NA,16,Terminated,Are Extended Urine Cultures More Sensitive Than Standard Urine Cultures in Diagnosing Urinary Tract Infections in Patients With Urgency and Frequency?,Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections
NCT03091777,2020-01-02,"March 10, 2017","March 27, 2018","November 15, 2017",2017-03-21,2019-08-01,Interventional,Phase 3,871,Completed,"A Multicenter, Randomized, Double-Blind, Vehicle Controlled Study Evaluating the Therapeutic Equivalence and Safety of GDC-229 (Investigational Metronidazole 0.75% Vaginal Gel) and Metronidazole 0.75% Vaginal Gel in the Treatment of Bacterial Vaginosis",Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
NCT03093194,2017-04-03,"April 10, 2017","April 30, 2020","April 30, 2019",2017-03-12,NA,Interventional,Not Applicable,1040,Unknown status,Vaginal Antimicrobacterial Preparation Before Cesarean Secation for Endometritis Prevention,Vaginal Antimicrobacterial Preparation Before Cesarean Secation for Endometritis Prevention
NCT03099863,2021-12-01,April 2016,June 2020,June 2020,2017-03-23,2021-10-18,Interventional,Phase 4,242,Completed,Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Infection: A Randomized Controlled Study,Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
NCT03101371,2020-03-06,"October 10, 2017","February 15, 2019","February 15, 2019",2017-03-30,2020-02-03,Interventional,Phase 2,99,Completed,Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion,Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion
NCT03108079,2017-04-10,April 2017,June 2017,May 2017,2017-03-30,NA,Interventional,Not Applicable,3,Unknown status,Bladder Morphology Using 2 Different Catheter Designs Foley Catheter vs. Cystosure Urinary Access System,Bladder Morphology Using 2 Different Catheter Designs
NCT03122704,2017-04-17,October 2015,September 2016,August 2016,2015-10-21,NA,Interventional,Not Applicable,0,Withdrawn,Prevalence of Group B Streptococcus Infection in Pregnant Women Conceived Through IVF Diagnosed With Preterm Labor.,Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
NCT03127280,2018-01-26,"November 4, 2014","January 14, 2018","January 1, 2018",2017-04-13,NA,Interventional,Not Applicable,200,Completed,Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?,Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?
NCT03129295,2017-04-21,April 2017,September 2017,September 2017,2017-04-19,NA,Interventional,Phase 2,200,Unknown status,"A Randomized, Double-Blind, Placebo-Controlled, MultiCenter Study of the Efficacy and Safety of MPC-SHRC for the Relief of Symptoms Associated With Uncomplicated Urinary Tract Infections",Phase II Proof of Concept Study in Uncomplicated UTI
NCT03142295,2017-06-23,"June 24, 2017","February 1, 2018","January 1, 2018",2017-05-03,NA,Interventional,Not Applicable,6,Unknown status,Safety and Tolerability of Controlled Human Urine Transfusion for Urinary Tract Infection Prevention (SHUTUP): a Pilot Study,Controlled Human Urine Transfusion for UTI
NCT03143920,2022-07-07,"November 1, 2017","July 7, 2022","July 7, 2022",2017-05-02,NA,Interventional,Early Phase 1,11,Terminated,Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder: A Feasibility Trial,Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
NCT03151603,2019-11-26,"May 3, 2017","June 20, 2019","May 19, 2019",2017-05-10,NA,Interventional,Phase 4,398,Completed,Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial,Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial
NCT03151967,2023-02-06,September 2015,"April 5, 2017","April 5, 2017",2016-01-13,2022-12-16,Interventional,Phase 2/Phase 3,27,Completed,Lactobacillus Probiotic for Prevention of UTI,Lactobacillus Probiotic for Prevention of UTI
NCT03158220,2019-11-04,"September 20, 2017","November 19, 2018","November 19, 2018",2017-05-16,2019-11-04,Interventional,Phase 3,1212,Completed,An Open-Label Phase III Clinical Trial to Study the Immunogenicity and Tolerability of GARDASIL®9 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Adult Women (27- to 45-Year-Olds) Compared to Young Adult Women (16 to 26 Year Olds),Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
NCT03167957,2019-03-06,December 2019,December 2020,December 2020,2017-05-23,NA,Interventional,Phase 2,0,Withdrawn,"A Single-Center, Open-Label, Pilot Study to Evaluate the Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis",Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis
NCT03168178,2018-10-21,"June 8, 2017","July 26, 2018","July 26, 2018",2017-05-18,NA,Interventional,Phase 4,0,Withdrawn,A Randomized Trial in Intrapartum Fever Of No Antibiotics for Low-risk Women (RATIONAL),Intrapartum Fever: Antibiotics Versus no Treatment
NCT03176563,2019-11-26,"May 3, 2017","August 20, 2019","July 19, 2019",2017-05-31,NA,Observational,NA,398,Completed,Observational Study of Patients With Uncomplicated Urinary Tract Infection Treated With Antibiotics or Herbal Medicinal Product,Observational Follow-up Study of REGATTA
NCT03178734,2020-07-26,"July 22, 2016","June 30, 2019","June 14, 2019",2017-05-11,NA,Interventional,Not Applicable,100,Completed,Foley Catheter vs a Self-contained Valved Urinary Catheter for Patients Who Are Being Discharged Home With a Catheter After Urogynecologic Procedures,Foley Catheter vs a Self-contained Valved Urinary Catheter
NCT03185169,2018-07-23,"November 18, 2016","July 23, 2018","July 23, 2018",2017-05-26,NA,Interventional,Early Phase 1,14,Terminated,GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors,GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
NCT03187457,2017-12-12,"September 4, 2017","November 14, 2017","November 14, 2017",2017-05-18,NA,Interventional,Not Applicable,60,Completed,"PreFem: ""What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?""","PreFem: ""What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"""
NCT03190421,2020-06-11,"June 15, 2017","April 30, 2020","March 30, 2020",2017-06-14,NA,Interventional,Not Applicable,225,Completed,The Use of Expanded Quantitative Urinary Culture (EQUC) Versus Standard Culture (SUC) Techniques in the Clinical Care of Women With Symptoms of Urinary Tract Infections.,Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care
NCT03206255,2019-01-03,"July 1, 2017","August 15, 2018","August 15, 2018",2017-06-30,NA,Observational,NA,940,Completed,"Immuno-persistence Study of A Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Female Subjects Aged 9 to 17 Years",Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
NCT03229603,2017-12-21,April 2018,May 2018,April 2018,2017-04-18,NA,Interventional,Not Applicable,227,Unknown status,A Pilot Study on HPV and Cervical Cancer Screening in Mumbai,A Pilot Study on HPV and Cervical Cancer Screening in Mumbai
NCT03239223,2019-07-08,"January 1, 2018","October 30, 2018","October 30, 2018",2017-08-01,NA,Interventional,Phase 1,16,Completed,"A Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Subjects With Cervical High Grade Squamous Intreaepithelial Lesions (cHSIL)",Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
NCT03248297,2022-03-18,"January 12, 2018","October 1, 2020","May 15, 2020",2017-07-25,2021-11-16,Interventional,Phase 4,756,Completed,Azithromycin With or Without Amoxicillin to Prevent Peripartum Infection and Sepsis in Laboring High-risk Women: 3-Arm RCT,Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries
NCT03251898,2020-04-23,"August 15, 2017","April 30, 2018","March 31, 2018",2017-08-15,NA,Observational [Patient Registry],NA,15926,Completed,Multicenter Study on Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections,Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections
NCT03284866,2024-01-22,"July 31, 2019","March 15, 2027","December 2, 2024",2017-05-04,NA,Interventional,Phase 3,536,"Active, not recruiting","A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions Among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)",HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV
NCT03287089,2022-08-05,"September 29, 2017","June 1, 2019","May 30, 2019",2017-09-15,2020-04-22,Interventional,Phase 4,164,Completed,Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery (NAUTICA): A Randomized Controlled Trial,Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
NCT03297216,2021-07-21,"February 7, 2018","August 6, 2020","June 25, 2020",2017-09-15,2021-05-07,Interventional,Phase 3,800,Completed,Z 31702 - Improving Pregnancy Outcomes With Progesterone (IPOP): a Trial of 17-Hydroxyprogesterone Caproate to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy,Improving Pregnancy Outcomes With Progesterone
NCT03299387,2019-06-04,"June 28, 2017","July 5, 2018","July 5, 2018",2017-09-20,NA,Interventional,Phase 4,0,Withdrawn,INtravesical Antimicrobial Agents Versus STANDard Oral Antibiotics for the Treatment of Acute Urinary Tract Infection in Women With Recurrent Urinary Tract Infection (INSTANT Study),INtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTI
NCT03305991,2024-03-12,"December 1, 2015","March 12, 2024","March 12, 2024",2017-10-02,NA,Observational,NA,2120,Completed,The Role of Maternal TB Infection for Adverse Pregnancy and Infant Health Outcomes in Ethiopia - a Long-term Prospective Cohort Study,Tuberculosis Infection in Women of Reproductive Age and Their Infants
NCT03306719,2017-10-10,"April 5, 2017","December 31, 2018","June 30, 2018",2017-10-01,NA,Observational,NA,50,Unknown status,Circulating Cell-free Mitochondrial as a Novel Biomarker for Intra-amniotic Infection in Obstetrics,mtDNA as Novel Biomarker for Intra-amniotic Infection
NCT03345875,2018-08-08,"October 16, 2017","June 30, 2018","June 30, 2018",2017-10-26,NA,Interventional,Not Applicable,1022,Completed,Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Clinics and the Community in Botswana,Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana
NCT03347513,2018-12-02,"November 25, 2017",May 2019,March 2019,2017-11-15,NA,Interventional,Phase 4,150,Unknown status,Does Eradication of H-pylori in Pregnant Patients With Iron Deficiency Anemia Have an Effect on Iron Replacement Therapy?,Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?
NCT03354598,2020-12-17,"August 1, 2018","January 20, 2020","January 16, 2020",2017-11-20,2020-11-20,Interventional,Phase 3,1671,Completed,A Prospective Phase 3 Randomized Multi-center Double-blind Study of Efficacy Tolerability & Safety of Oral Sulopenem-etzadroxil/Probenecid vs Ciprofloxacin for Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women,Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
NCT03362697,2019-06-18,"December 15, 2017","June 18, 2019","December 30, 2018",2017-11-28,NA,Interventional,Not Applicable,150,Completed,Randomized Clinical Trial on the Safety and Efficacy of Lactobacillus Reuteri DSM 16666/ATCC 55845 & Lactobacillus Reuteri DSM 17938 for Treatment of Pregnant Women With Asymptomatic Bacteriuria or Uncomplicated Acute Cystitis,Lactobacillus Reuteri for Treatment of Uncomplicated UTI in Pregnant Women
NCT03366077,2020-12-31,"December 13, 2017","July 12, 2019","July 12, 2019",2017-12-04,NA,Interventional,Not Applicable,140,Completed,"A Double-blinded, Randomized, Placebo-controlled, Parallel-group Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection (UTI) in Adult Women Recently Treated for UTI.","Double-blinded, Randomized, Placebo-controlled Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection"
NCT03366207,2019-08-21,"December 15, 2017","October 26, 2018","July 31, 2018",2017-12-04,2019-07-31,Interventional,Phase 4,250,Completed,Clinical and Microbiologic Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection in Adult Women.,Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
NCT03386695,2018-08-03,September 2018,January 2020,January 2019,2017-04-18,NA,Interventional,Not Applicable,1600,Unknown status,Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra,Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra
NCT03391440,2017-12-29,September 2016,December 2018,December 2018,2017-11-28,NA,Interventional,Phase 4,469,Unknown status,An Open-Lable Multicenter Prospective Non-Randomized Trial to Assess the Efficacy and Safety of Morinidazole With Levofloxacin and Sequential of Levofloxacin in Women With Pelvic Inflammatory Disease,A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
NCT03395288,2022-01-07,"March 22, 2018","April 25, 2020","April 25, 2020",2017-12-28,2021-05-12,Interventional,Phase 2/Phase 3,61,Terminated,"Randomized, Controlled Trial to Determine the Efficacy of Nutraceutical vs Control as Non-antibiotic Prophylaxis for Recurrent Urinary Tract Infection in Postmenopausal Women Using Vaginal Estrogen Therapy",Nutraceutical Efficacy for rUTI
NCT03397615,2019-07-24,"January 3, 2019",December 2019,December 2019,2018-01-06,NA,Interventional,Not Applicable,1200,Unknown status,Effect of Vaginal Douching With Betadine Versus Non Douching Before CS for Prevention of Post Operative Infections,Effect of Vaginal Douching With Betadine Before CS for Prevention of Post Operative Infections
NCT03413774,2018-01-22,"October 1, 2014","January 15, 2018","December 20, 2017",2018-01-22,NA,Observational,NA,1850,Completed,Unexplained Early Miscarriage : Role and Prevalence of Lower Genital Tract Infections in Rural Area in Egypt,Unexplained Early Miscarriage : Role and Prevalence of Lower Genital Tract Infections
NCT03425396,2020-06-05,"January 4, 2018","June 5, 2019","May 15, 2019",2017-12-28,2020-05-15,Interventional,Phase 2,225,Completed,"A Randomized, Double-Blinded, Adaptive Phase 2 Study to Evaluate the Safety and Efficacy of Oral Omadacycline and Oral Nitrofurantoin in the Treatment of Female Adults With Cystitis",Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
NCT03442218,2019-12-05,"June 1, 2017","February 28, 2018","August 31, 2017",2018-02-13,NA,Interventional,Not Applicable,203,Completed,"Use fo Antiseptic Solution for Vaginal Wash Before Cesarean Section in Patients With Premature Rupture of Membranes. A Randomized, Double Blind, Controlled Trial.",Use of Antiseptic Solution for Vaginal Wash Before Cesarean Section
NCT03443154,2018-06-25,June 2018,"June 1, 2018","June 1, 2018",2018-02-16,NA,Observational,NA,0,Withdrawn,"Vaginal Fluid (VF) Test VF-Test™ for Prediction of Extremely Preterm Birth After Exam-Indicated Cerclage Protocol for Prospective, Multicenter, Cohort Clinical Trial",VF Test for Prediction of Extremely PTB After Cerclage
NCT03490045,2023-04-20,"April 1, 2019","August 17, 2020","August 17, 2020",2018-03-29,NA,Interventional,Not Applicable,77,Completed,Examining the Impact of an Intervention to Reduce Diaper Need and Increase Use of Pediatric Preventive Care,Intervention to Reduce Diaper Need and Increase Use of Pediatric Preventive Care
NCT03497598,2020-09-01,"May 9, 2018","May 31, 2020","May 31, 2020",2018-04-05,NA,Interventional,Phase 4,15,Terminated,"Preventing Recurrent Urinary Tract Infections With α-D-mannose: a Prospective, Randomized, Double-blinded Placebo-controlled Trial",Preventing Recurrent Urinary Tract Infections With α-D-mannose
NCT03519373,2022-09-29,"March 1, 2017","June 1, 2019","June 1, 2019",2018-04-26,NA,Observational,NA,135,Completed,Impact of HIV Infection and Pregnancy on Humoral Responses to Pertussis Immunization,Pertussis Immunization During Pregnancy & HIV Infection
NCT03522961,2023-08-25,"August 15, 2018","January 31, 2024","September 30, 2023",2018-04-17,NA,Interventional,Not Applicable,142,"Active, not recruiting",Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery: a Double-blinded Randomized Clinical Trial,Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
NCT03548129,2018-05-24,July 2016,August 2018,July 2018,2016-06-09,NA,Interventional,Phase 2,88,Unknown status,Empirical Use of Fosfomycin as a Single Dose Oral Treatment of Asymptomatic Bacteriuria,the Use of Fosfomycin as a Single Dose Oral Treatment of Asymptomatic Bacteriuria
NCT03561701,2021-12-17,"August 23, 2018","August 3, 2021","October 13, 2020",2018-06-01,2021-10-12,Interventional,Phase 3,425,Completed,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis",A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT03562156,2022-04-04,"August 16, 2018","August 6, 2021","October 19, 2020",2018-06-01,2021-10-19,Interventional,Phase 3,438,Completed,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis",A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT03568942,2020-06-12,"July 23, 2018","January 7, 2019","January 7, 2019",2018-06-11,2019-12-13,Interventional,Phase 2,22,Completed,"A Phase IIa Single-Center, Open-Label Study Evaluating the Pharmacokinetics of Repeat Oral Doses of Gepotidacin (GSK2140944) in Adult Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)",Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
NCT03570112,2024-02-06,"June 8, 2018","February 27, 2023","November 22, 2022",2018-06-06,NA,Observational,NA,40,Completed,Evaluation of the Natural History and Vertical Transmission of Chronic Hepatitis C Virus Infection in Pregnancy With Targeted Elimination by Postpartum Treatment,Transmission of Chronic Hepatitis C in Pregnancy
NCT03581617,2018-06-26,"November 1, 2014","November 1, 2016","November 1, 2015",2018-06-04,NA,Observational,NA,143,Completed,Prognostic Markers in Women With Primary Unexplained Infertility,Infections and Unexplained Infertility
NCT03585023,2018-06-30,"November 15, 2014","May 14, 2017","November 15, 2016",2018-06-04,NA,Observational,NA,200,Completed,Silent Intracellular Infections and Early Pregnancy Loss,Infections and Pregnancy Loss: Correlation Between Abortion and Silent Infections.
NCT03597152,2020-01-08,"August 1, 2020","December 31, 2022","January 14, 2022",2018-07-13,NA,Interventional,Not Applicable,250,Unknown status,Nutritional Supplementation for Extending Time Between Recurrent Urinary Tract Infections in Women: a Randomized Double Blind Cross-over Trial,Nutritional Supplementation for Recurrent Urinary Tract Infections in Women
NCT03614286,2018-08-04,October 2018,March 2020,October 2019,2018-07-30,NA,Observational,NA,20,Unknown status,Trichomonas Vaginalis Genotyping in Upper Egypt,Trichomonas Vaginalis Genotyping in Upper Egypt
NCT03633994,2019-10-08,"August 20, 2018","March 1, 2020","December 31, 2019",2018-08-13,NA,Interventional,Phase 2,104,Unknown status,Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy: A Randomized Controlled Trial,Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy
NCT03638427,2022-12-01,"January 1, 2019","January 1, 2024","May 31, 2023",2018-08-16,NA,Observational,NA,200,Enrolling by invitation,Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood,Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
NCT03644966,2023-04-10,"July 5, 2018","December 15, 2022","December 15, 2022",2018-08-06,NA,Interventional,Not Applicable,25,Completed,Probiotic and Effects on Multi-Drug Resistant Urinary Tract Infection,Probiotics and Multi-Drug Resistant Urinary Tract Infection
NCT03672214,2019-04-24,"June 1, 2019","November 1, 2023","June 1, 2023",2018-09-13,NA,Interventional,Not Applicable,400,Unknown status,Caesarean Delivery With or Without an Indwelling Bladder Catheter,Caesarean Delivery With or Without an Indwelling Bladder Catheter
NCT03681678,2023-05-13,"October 8, 2018",October 2025,"December 15, 2022",2018-08-03,NA,Observational [Patient Registry],NA,100,"Active, not recruiting",Fractional Carbon Dioxide Laser Therapy of the Vagina for Treatment of Urogenital Symptoms in Women,Laser Therapy for Treatment of Urogenital Symptoms in Women
NCT03697226,2021-01-11,"December 21, 2018","June 12, 2020","May 26, 2020",2018-09-25,NA,Interventional,Phase 1,8,Completed,"An Open-Label Multiple-Dose, Dose Escalation Study To Evaluate Safety, Tolerability and Pharmacokinetics of Topical ABI-1968 in Participants With Cervical High Grade Squamous Intraepithelial Lesions",Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
NCT03719755,2024-03-23,"February 1, 2018","December 30, 2024","December 30, 2024",2018-10-19,NA,Interventional,Not Applicable,140,"Active, not recruiting",Comparison of Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid: a Prospective Study,Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
NCT03728790,2020-09-05,"November 9, 2018","May 11, 2020","July 28, 2019",2018-10-28,2020-07-24,Interventional,Not Applicable,213,Completed,A Remote Postpartum (PP) Blood Pressure Surveillance and Reminder System for Hypertensive Disorders of Pregnancy: A Randomized Clinical Trial,Remote BP Monitoring in the PP Period
NCT03729336,2019-06-04,"February 6, 2019","June 1, 2019","April 12, 2019",2018-10-26,NA,Interventional,Not Applicable,74,Completed,Midstream Urine Collection Device Compared to Catheterized Sample: Contamination and Patient Satisfaction.,PEEZY Midstream Urine Device Compared to Catheterized Urine Sample
NCT03749746,2021-12-02,"January 26, 2019","December 1, 2021","December 1, 2021",2018-11-20,NA,Interventional,Not Applicable,148,Completed,Heart Health 4 New Moms: A Randomized Controlled Trial of a Lifestyle Intervention and Home Blood Pressure Monitoring Following Preeclampsia in Overweight and Obese Women,Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia
NCT03771651,2023-11-20,"March 1, 2019",June 2025,"May 6, 2022",2018-12-07,NA,Interventional,Early Phase 1,18,"Active, not recruiting",A Surgical Window Pilot Investigation of Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube,Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
NCT03779347,2021-07-26,"May 1, 2019","May 1, 2022","April 1, 2022",2018-12-08,NA,Interventional,Phase 3,100,Unknown status,"Prospective, Observational Study to Assess the Performance of CAA Measurement as a Diagnostic Tool for the Detection of Schistosoma Haematobium Infections in Pregnant Women and Their Newborn and Child in Lambaréné, Gabon",Schistosomiasis Diagnosis Using a CAA Antigen Test
NCT03789513,2022-02-15,"March 1, 2019",September 2022,"September 1, 2022",2018-09-03,NA,Interventional,Not Applicable,3000,Unknown status,Evaluation of Screening Algorithms Based on Self-collection and HPV Testing With Partial Genotyping for the Prevention of Cervical Cancer Among HIV-infected Women in Low-income Countries,Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women
NCT03800667,2019-07-12,"August 8, 2018","July 12, 2019","July 12, 2019",2019-01-09,NA,Interventional,Early Phase 1,0,Withdrawn,Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries: a Study Protocol for a Randomized Controlled Trial,Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries
NCT03813576,2019-01-20,March 2019,December 2019,August 2019,2019-01-20,NA,Interventional,Not Applicable,300,Unknown status,Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study,Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
NCT03818321,2022-10-19,"June 17, 2019","July 1, 2021","July 1, 2021",2019-01-23,2022-10-19,Interventional,Phase 2,185,Completed,Methenamine Hippurate With Cranberry Capsules Versus Cranberry Capsules Alone for UTI Prevention in a Short-term Indwelling Foley Catheter Population After Urogynecological Surgery: A Double-Blinded Randomized Controlled Trial,Urinary Track Infection Prevention After Urogynecological Surgery
NCT03819712,2023-12-11,"June 3, 2019","December 7, 2023","December 3, 2023",2019-01-25,NA,Interventional,Not Applicable,109,Completed,Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections,Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections
NCT03826342,2024-04-05,"April 16, 2019",July 2024,"March 8, 2024",2019-01-30,NA,Interventional,Not Applicable,250,"Active, not recruiting",Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy,Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy
NCT03828994,2024-02-23,"February 10, 2019","March 31, 2025","December 31, 2024",2019-02-01,NA,Interventional,Not Applicable,150,"Active, not recruiting",Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID,Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II
NCT03834571,2022-06-14,"May 31, 2022",January 2025,January 2025,2019-02-06,NA,Interventional,Phase 2,0,Withdrawn,A Randomized Phase II Trial of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Paclitaxel and Carboplatin in HIV-positive Women With Locally Advanced Cervical Cancer (LACC),Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women
NCT03837015,2021-12-16,"November 4, 2019","December 14, 2021","December 14, 2021",2019-02-08,NA,Interventional,Phase 1,50,Completed,"Improving Vaginal Health to Decrease Biological Risk of HIV-1 Infection in Canadian African, Caribbean and Black (ACB) Women: Estrogen and Probiotic Treatment for Vaginal Health","Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women"
NCT03838965,2022-06-22,"March 1, 2019","December 16, 2020","December 16, 2020",2019-01-30,NA,Interventional,Not Applicable,100,Completed,"The Effects of Labor Stages and Interventions on Hemodynamic Measures During and After Childbirth (Epidural, Rupture of Membranes, Cesarean Sections and Preeclampsia) With Noninvasive Sensors.",The Effects of Labor Stages and Interventions on Hemodynamic Measures During & After Childbirth With Noninvasive Sensors
NCT03839875,2020-01-30,"April 3, 2019","August 9, 2019","August 9, 2019",2019-02-11,NA,Interventional,Phase 4,116,Completed,"A National, Multi-central, Open-label, Single-arm, Phase IV Study to Evaluate Efficacy and Safety of Gynomax® XL Ovule in the Treatment of Trichomonal Vaginitis, Bacterial Vaginosis, Candidal Vulvovaginitis and Mixed Vaginal Infections",Evaluation of Efficacy and Safety of Gynomax® XL Ovule
NCT03840616,2022-02-03,"March 13, 2019","December 2, 2020","December 2, 2020",2019-02-11,2021-11-29,Interventional,Phase 3,219,Completed,"Phase 3, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules vs Fluconazole and Placebo in Treatment of Acute Vulvovaginal Candidiasis in Subjects With Recurrent Vulvovaginal Candidiasis",Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections
NCT03854396,2021-06-25,May 2020,February 2021,February 2021,2019-02-24,NA,Interventional,Phase 3,0,Withdrawn,"A Randomized, Double-blind, Placebo-controlled Trial on the Preventive Effect of Intravaginal Prasterone (DHEA, Intrarosa®) on Recurrent Urinary Tract Infections in Women With Genitourinary Syndrome of Menopause",Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
NCT03861260,2021-09-21,"April 30, 2019","October 28, 2019","October 28, 2019",2018-05-03,NA,Interventional,Not Applicable,0,Withdrawn,To Investigate and Compare The Efficacy of Urethral Dilatation Versus Glycosaminoglycan Layer Replacement in The Management Of Women With Recurrent Urinary Tract Infections,GAG Replacement vs URethral DIlAtatioN
NCT03871491,2023-05-09,"September 1, 2020","September 30, 2024","October 7, 2022",2019-03-05,NA,Interventional,Phase 3,34000,"Active, not recruiting",Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial,Azithromycin-Prevention in Labor Use Study (A-PLUS)
NCT03898167,2023-06-07,"February 13, 2020",May 2024,"December 31, 2023",2019-03-29,NA,Interventional,Not Applicable,2268,Enrolling by invitation,A Randomized Controlled Trial of Mailed Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System,Prospective Evaluation of Self-Testing to Increase Screening
NCT03898310,2023-06-12,"February 5, 2019","January 22, 2023","January 22, 2023",2019-02-27,NA,Interventional,Not Applicable,141,Completed,UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery,UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery
NCT03914144,2019-04-11,"May 1, 2019","August 1, 2019","August 1, 2019",2019-04-11,NA,Observational,NA,638,Unknown status,Postnatal Prevalence of Bacteriuria in Women With Catheter Versus no Catheter in Labour: a Prospective Cohort Study,Postnatal Prevalence of Bacteriuria in Women With Catheter Versus no Catheter in Labour: a Prospective Cohort Study
NCT03929991,2019-04-29,"May 1, 2018","May 1, 2020","October 1, 2019",2019-04-24,NA,Observational,NA,1000,Unknown status,Maternal Cesarian Section Infection (MACSI) in Sierra Leone: an Observational Study,Maternal Cesarian Section Infection (MACSI) in Sierra Leone
NCT03930017,2023-01-04,"October 14, 2018","January 6, 2020","January 6, 2020",2017-08-16,NA,Observational,NA,784,Completed,Arsenic and Immune Response to Influenza Vaccination in Pregnant Women and Newborns,"Pregnancy, Arsenic and Immune Response"
NCT03954990,2023-12-11,"October 11, 2019","September 26, 2022","September 26, 2022",2019-04-23,NA,Interventional,Phase 1,75,Terminated,Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity: A Randomized Controlled Trial,Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity
NCT03959410,2023-04-11,"January 4, 2019","January 1, 2022","December 10, 2021",2019-05-21,NA,Interventional,Not Applicable,150,Completed,"Impact of HPV on a Cohort of Southern Italian Women: a Prospective Observational Study About Epidemiological, Clinical, Morphological and Microbiological Features of HPV Infection","Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features"
NCT03960970,2019-09-15,"September 15, 2019","November 30, 2020","September 30, 2019",2019-05-21,NA,Interventional,Phase 2,800,Unknown status,Azithromycin-based Extended-spectrum Prophylaxis in Scheduled Cesarean Deliveries,Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
NCT03961178,2019-06-19,"June 3, 2019","May 22, 2021","May 22, 2021",2019-05-22,NA,Observational,NA,10000,Unknown status,Oncologic and Obstetric Outcomes After Conization for Uterine Cervical Lesion: A Cohort Study,A Cohort Study for the Following up of Conization
NCT03975569,2019-06-03,"April 4, 2016","March 31, 2017","March 31, 2017",2019-02-12,NA,Interventional,Not Applicable,20,Completed,Studie Van de Vaginale Microbiota en Het Potentieel Van Een Vaginale Zalf Met Probiotica Bij Vaginale Candidose,Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis
NCT03981458,2019-07-03,"July 1, 2019",July 2020,July 2020,2019-01-29,NA,Interventional,Not Applicable,40,Unknown status,Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis,Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis
NCT03987620,2021-08-11,"June 7, 2019","April 29, 2020","March 29, 2020",2019-06-12,2021-06-30,Interventional,Phase 3,455,Completed,"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (AVVC).",Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
NCT03994055,2023-09-18,"November 16, 2018",January 2024,"April 28, 2023",2018-10-18,NA,Interventional,Not Applicable,136,"Active, not recruiting",Effect of an Anti-inflammatory Diet on the Nutritional Status and Cytokine Expression of Patients With Locally Advanced Cervical Cancer: A Randomized Clinical Trial,Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer
NCT03996057,2022-07-06,"June 20, 2018","February 11, 2022","February 11, 2022",2019-06-17,NA,Interventional,Phase 4,0,Withdrawn,"The Efficacy and Effect of Methenamine Hippurate in a Non-antibiotic, Multimodal Approach to UTI Prevention","Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention"
NCT04000503,2022-10-31,"August 1, 2019","October 31, 2022","July 31, 2021",2019-06-18,NA,Interventional,Not Applicable,2019,Completed,Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge): A Pragmatic Cluster Randomized Control Trial,Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)
NCT04020341,2023-05-29,"October 17, 2019","November 30, 2022","November 30, 2022",2019-07-11,2023-05-29,Interventional,Phase 3,1531,Completed,"A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)",A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
NCT04022148,2019-07-17,"August 1, 2019","December 31, 2020","December 31, 2020",2019-07-14,NA,Observational [Patient Registry],NA,2800,Unknown status,"A Nonrandomized, Non-double Blinded Prospective Cohort Study to Evaluate the Preventive Efficacy of Quadrivalent HPV6/11/16/18 Vaccine for the Persistent Infection of HPV16 Genotype or HPV18 Genotype in Japanese Women Aged 27-45 Years.",The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years
NCT04024046,2022-09-26,"April 18, 2019","September 16, 2020","September 16, 2020",2019-07-16,NA,Observational,NA,360,Terminated,Evaluation of the Impact of the Uqora Dietary Supplement Products on Urinary Tract Infection (UTI) Incidence in Women With Recurring UTIs,Uqora Supplements in Women With UTIs
NCT04031664,2019-07-29,"August 2, 2019","December 31, 2020","August 2, 2019",2019-07-11,NA,Interventional,Phase 4,184,Unknown status,"A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)：a Randomized, Double Blind, Parallel Control of Positive Drugs, Multi-center Clinical Study",A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)
NCT04032574,2019-07-25,"October 8, 1991","March 27, 1992","March 27, 1992",2019-07-23,NA,Interventional,Phase 3,200,Completed,"Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Group Trial to Evaluate the Efficacy and Tolerability of a Phytotherapy Combination (Aqualibra) in Patients With Uncomplicated Cystitis",Efficacy and Tolerability of a Phytotherapy Combination (Aqualibra) in Patients With Uncomplicated Cystitis
NCT04035785,2019-07-25,"July 28, 2019","December 31, 2020","July 28, 2019",2019-07-11,NA,Interventional,Phase 4,240,Unknown status,"A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation):a Randomized, Double Blind, Parallel Control of Positive Drugs,Multi-center Clinical Study",A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)
NCT04045652,2023-05-17,"November 18, 2021","October 1, 2026","October 1, 2025",2019-07-08,NA,Observational,NA,220,Recruiting,Modifiable Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women,Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women
NCT04048356,2023-06-20,"July 15, 2019","March 14, 2021","February 28, 2021",2019-08-02,2023-06-20,Interventional,Phase 3,137,Completed,Chlorhexidine Gluconate Versus Povidone Iodine for Vaginal Surgical Preparation for Urogynecological Procedures,Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures
NCT04057924,2023-12-06,"August 23, 2019","September 1, 2029","September 1, 2029",2019-07-04,NA,Observational,NA,200,Recruiting,Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN,Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
NCT04072913,2019-08-27,"October 10, 2007","January 31, 2011","January 31, 2011",2019-08-26,NA,Interventional,Not Applicable,216,Completed,Involvement of Matrix Metalloproteinases and Association With the Expression of Human Papillomavirus in Dysplasias and Cancers of the Cervix,Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
NCT04077580,2023-06-27,"November 1, 2019","November 30, 2023","November 30, 2023",2019-08-12,NA,Interventional,Phase 4,400,Enrolling by invitation,"The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing Due to New Episodes of Urinary Tract Infections (UTI) in Elderly Women With Recurrent UTI - a Triple- Blinded, Randomized Placebo-controlled Phase IV Study",The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI
NCT04079218,2024-02-01,"September 1, 2020","August 9, 2023","August 9, 2023",2019-09-03,NA,Interventional,Phase 4,51,Completed,The Impact of HIV on Accelerated Aging in the Female Genital Tract: a Pilot Trial of Topical Estradiol to Improve the Vaginal Microbiome and Symptoms of Vaginal Atrophy in Menopausal Women With HIV,Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial
NCT04092257,2024-03-13,"June 24, 2020","February 28, 2025","February 28, 2024",2019-09-13,NA,Interventional,Not Applicable,1250,"Active, not recruiting",A Novel Cervical Cancer Screen-and-Treat Demonstration Project With HPV Self-testing and Thermocoagulation for HIV-infected Women in Lilongwe Malawi,HPV-Based Screen-and-Treat Demonstration Project in Lilongwe
NCT04095572,2024-02-06,"October 27, 2020",June 2026,June 2025,2019-09-17,NA,Interventional,Phase 4,50,Recruiting,"Non-antimicrobial Alternative in Prophylaxis of Recurrent Urinary Tract Infections: a Prospective, Randomised-controlled, Double-blinded, Multicentre Study",Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
NCT04096820,2022-07-28,"September 6, 2019","January 1, 2023","October 31, 2022",2019-09-18,NA,Interventional,Phase 2,62,"Active, not recruiting","Protocol 19-01: Canadian, Single Centre, Pilot, Open Label Study to Evaluate the Efficacy and Safety of the Bacterial Vaccine Uromune in Treating Recurrent Urinary Tract Infections in Women.",Uromune in Treating Recurrent Urinary Tract Infections in Women
NCT04098744,2024-02-20,"September 9, 2020","December 31, 2025","July 31, 2025",2019-09-19,NA,Interventional,Phase 2,78,Recruiting,"A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Vaginal Inserts for the Treatment of Patients With Cervical Intraepithelial Neoplasia (CIN2/3)",Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
NCT04133610,2019-11-25,"September 1, 2018","November 25, 2019","October 30, 2019",2019-10-16,NA,Interventional,Not Applicable,1044,Completed,HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs,HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs
NCT04140669,2022-07-11,"September 16, 2019","July 7, 2020","July 7, 2020",2019-10-24,NA,Observational,NA,7,Terminated,"Automated Myocardial Performance Index Before, During and After Fetal Surgeries Using Samsung HERA W10",Automated Myocardial Performance Index Using Samsung HERA W10
NCT04152278,2020-07-21,"September 1, 2017","September 30, 2019","August 30, 2019",2019-11-02,NA,Observational,NA,600,Completed,Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage,Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
NCT04155294,2022-05-17,"October 28, 2019","October 31, 2021","October 31, 2021",2019-10-18,NA,Observational,NA,71,Completed,Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention (REACH-UP): a Feasibility Study in Women Living With HIV,Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV
NCT04163679,2021-10-06,"September 18, 2019","July 30, 2021","July 30, 2021",2019-11-08,NA,Interventional,Not Applicable,84,Terminated,Combining Vaginal Preparation and Azithromycin in Reduction of Post Cesarean Infections: A Randomized Controlled Trial,Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections
NCT04165252,2021-06-01,"April 1, 2020","December 1, 2022","December 1, 2021",2019-10-14,NA,Observational [Patient Registry],NA,92,Unknown status,"Evaluation of the Relationship Between Vaginal, Placental and Neonatal Mycobiota and Microbiome With Preterm Birth in Women With Short Cervical Length","Vaginal, Placental and Neonatal Buccal Mycobiota and Microbiome in Preterm Birth"
NCT04171388,2020-08-13,"March 1, 2020","November 30, 2021","May 28, 2021",2019-10-09,NA,Interventional,Phase 4,0,Withdrawn,"Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Amhara Region, Ethiopia",Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia
NCT04187144,2023-07-15,"April 23, 2020","December 1, 2022","December 1, 2022",2019-12-03,2023-05-29,Interventional,Phase 3,1606,Completed,"A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)",Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
NCT04189744,2023-05-19,"December 15, 2019","March 31, 2023","October 21, 2022",2019-10-28,NA,Interventional,Phase 3,5436,Completed,Effects of Metronidazole Plus Intermittent Preventive Treatment of Malaria in Pregnancy on Birth Outcomes: a Randomised Controlled Trial in Zambia,The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract
NCT04226313,2024-01-02,"September 23, 2019","December 1, 2024","December 1, 2024",2020-01-09,NA,Interventional,Not Applicable,15000,Recruiting,Cervical Cancer Prevention Using Self-sampling and Human Papillomavirus Detection,Self-sampling for Non-attenders to Cervical Cancer Screening
NCT04244526,2020-01-28,"March 1, 2020","May 1, 2021","March 1, 2021",2020-01-25,NA,Observational,NA,155,Unknown status,Distribution of Virulence Genes and Their Association With Clinical Presentation of Urinary Tract Infection and Antimicrobial Resistance Among Uropathogenic Escherichia Coli Isolated From Pregnant Women,Urinary Tract Infection in Pregnancy
NCT04246996,2022-10-17,"January 29, 2020","December 5, 2021","December 5, 2021",2020-01-27,2022-09-21,Interventional,Phase 2,370,Completed,Gentamicin Intravesical Efficacy for Infection of Urinary Tract,Gentamicin Intravesical Efficacy for Infection of Urinary Tract
NCT04261036,2023-05-26,"July 20, 2019","October 1, 2021","July 1, 2021",2020-02-06,NA,Interventional,Early Phase 1,0,Withdrawn,Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries: a Study Protocol for a Randomized Double Blinded Controlled Trial.,Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries
NCT04278326,2023-05-05,"March 6, 2020",April 2024,April 2024,2020-02-18,NA,Interventional,Not Applicable,50,Recruiting,Primary Organoid Models and Combined Nucleic Acids Therapeutics for Innovative Anti-HPV Treatments in Cervico-vaginal Cancers and Precancerous Lesions,Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments
NCT04285320,2021-01-13,March 2021,April 2023,April 2023,2020-02-17,NA,Interventional,Phase 4,100,Unknown status,Intravesical Antibiotic Instillations Versus Oral Suppression for the Treatment of Recurrent Urinary Tract Infections in Post-menopausal Women,Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections
NCT04287504,2021-03-18,"February 14, 2020","July 31, 2021","March 18, 2021",2020-02-25,NA,Observational,NA,400,Unknown status,Validation of the OSOM BVBLUE Test for Bacterial Vaginosis and the SavvyCheck Vaginal Yeast Test for Vaginal Candidosis: A Prospective Study,Point-of-care Tests for Bacterial Vaginosis and Candidosis
NCT04301934,2024-03-01,"June 1, 2020","April 30, 2023","April 30, 2023",2020-03-06,2024-03-01,Interventional,Not Applicable,12,Completed,Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection,Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection
NCT04305808,2024-03-08,"August 1, 2021","December 30, 2024","December 30, 2024",2020-03-10,NA,Observational,NA,40,Recruiting,"Characterization of Vaginal, Urinary and Fecal Microbiomes in Women With Recurrent Urinary Tract Infections","Characterization of Vaginal, Urinary and Fecal Microbiomes in Women With Recurrent Urinary Tract Infections"
NCT04306731,2020-03-13,"September 20, 2014","April 21, 2017","April 21, 2017",2020-03-11,NA,Interventional,Not Applicable,437,Completed,"A Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Use of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.",Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.
NCT04307069,2024-04-11,"May 1, 2020","May 1, 2024","May 1, 2024",2020-03-11,NA,Interventional,Not Applicable,524,Recruiting,Comparison Between Two Protocols for Management of Prelabor Rupture of the Membranes at Term,Management of Prelabor Rupture of the Membranes at Term
NCT04333212,2020-04-01,"December 12, 2012","July 8, 2014","December 30, 2013",2020-04-01,NA,Interventional,Not Applicable,1103,Completed,Human Papillomavirus Detection and Genotyping by DR. HPV Genotyping IVD Kit in Exfoliated Cells of the Uterine Cervix,HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix
NCT04353141,2020-05-05,"April 28, 2020","December 31, 2020","May 31, 2020",2020-04-16,NA,Observational,NA,1850,Unknown status,A Prospective International Lung UltraSound Analysis (ILUSA) Study in Tertiary Maternity Wards During the SARS-CoV-2 Pandemic,International Lung UltraSound Analysis (ILUSA) Study
NCT04385238,2021-01-05,"May 15, 2020","June 20, 2020","June 20, 2020",2020-05-10,2020-11-01,Observational,NA,6894,Completed,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic
NCT04385680,2022-09-22,"May 15, 2020","August 30, 2022","March 10, 2022",2020-05-09,NA,Interventional,Phase 1/Phase 2,840,Completed,The Impact of Chlorhexidine Preoperative Vaginal Preparation in Reducing the Post-cesarean Endometritis and Sepsis for Cases in Labor. A Randomized Controlled Trial,Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis
NCT04414527,2021-12-03,"March 13, 2020","July 31, 2021","July 31, 2021",2020-04-21,NA,Interventional,Not Applicable,675,Completed,Effects of Video-based Health Education on Health Status of Pregnant Mothers and Their Infants (From 0 to 6 Months) in Dirashe District Southern Ethiopia - a Cluster Randomized Controlled Trial.,Effects of Video-based Health Education on Maternal and Child Health in Ethiopia
NCT04416373,2020-06-03,"March 22, 2020",December 2023,December 2023,2020-05-29,NA,Observational,NA,300,Unknown status,COVID-19 and Pregnancy Outcomes: a Portuguese Collaboration Study,COVID-19 and Pregnancy Outcomes
NCT04433364,2024-04-15,"June 2, 2020","December 31, 2040","December 31, 2026",2020-06-15,NA,Observational [Patient Registry],NA,3834,"Active, not recruiting",COPE - COVID-19 in Pregnancy and Early Childhood - a Study Protocol for a Prospective Multicentre Cohort Study,COPE - COVID-19 in Pregnancy and Early Childhood
NCT04444440,2024-02-07,"July 6, 2021","June 30, 2025","June 30, 2025",2020-06-19,NA,Interventional,Phase 4,202,Recruiting,Prophylactic Antibiotics During Treatment of Idiopathic Overactive Bladder With Intradetrusor onabotulinumtoxinA for the Reduction of Postoperative UTI: a Randomized Blinded Placebo-controlled Trial,Antibiotic Prophylaxis for Bladder Botox
NCT04463758,2021-10-01,"May 11, 2020",October 2022,February 2022,2020-07-08,NA,Observational,NA,3060,Unknown status,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns
NCT04472377,2022-04-17,"May 29, 2020","April 18, 2022","December 21, 2021",2020-07-09,NA,Interventional,Not Applicable,1210,Completed,"Evaluate the Agreement of High-risk Human Papillomavirus Type Between Self-collected Vaginal Discharge Sample Using ""HygeiaTouch Self Sampling Kit for Woman"" and Physician Collected Sample From the Cervix",Agreement of hrHPV Type Between Self-collected Sample From Vaginal Fornix and Physician Collected Sample From the Cervical Surface
NCT04488991,2020-07-24,"July 23, 2020","March 1, 2021","March 1, 2021",2020-07-16,NA,Observational,NA,1005,Unknown status,Naboth Kisti ve HPV pozitifliği arasındaki ilişkinin araştırılması,Nabothian Cyst Protects or Facilitates Against Cervical Cancer
NCT04496726,2024-01-10,"January 1, 2021","June 1, 2023","June 1, 2023",2020-07-29,NA,Interventional,Phase 2,2,Terminated,"A Proof-of-concept, Feasibility Study to Investigate the Effect of Cranberry and Quillaia Extract Type II on Symptoms in Women With Uncomplicated Urinary Tract Infection and to Study the Modulation of the Urinary and Gut Microbiome Pre- and Post-antibiotic Use",Cranberry and Quillaja on Symptoms of Uncomplicated UTI
NCT04515108,2020-08-14,"March 10, 2020","August 10, 2020","August 5, 2020",2020-08-14,NA,Observational,NA,108,Completed,Comparison of Hematological Parameters and Perinatal Outcomes in COVID-19 Pregnancies and Healthy Pregnancy Cohort,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies
NCT04519502,2023-03-24,"June 23, 2020","November 4, 2021","August 31, 2021",2020-08-18,NA,Observational,NA,25604,Completed,Maternal Morbidity and Mortality During the COVID-19 Pandemic,Maternal Morbidity and Mortality During the COVID-19 Pandemic
NCT04552210,2020-11-07,"September 16, 2020","February 20, 2021","December 15, 2020",2020-09-11,NA,Observational,NA,50,Unknown status,Mannose Binding Lectin Gene Polymorphism Versus Microbial Virulence in the Pathogenesis of Vulvovaginal Candidiasis in Egypt,Mannose Binding Lectin Gene Polymorphism Versus Microbial Virulence in the Pathogenesis of Vulvovaginal Candidiasis
NCT04558996,2020-09-18,"March 1, 2020","March 31, 2021","December 31, 2020",2020-09-18,NA,Observational [Patient Registry],NA,3000,Unknown status,REGISTRO EPIDEMIOLOGICO DE COVID 19 EN GESTANTES,Spanish Registry of Pregnant Women With COVID-19
NCT04578015,2023-05-21,"April 26, 2021","February 9, 2022","February 9, 2022",2020-10-01,2023-03-20,Interventional,Phase 4,16,Terminated,A Randomized Controlled Trial of Treatment of Bacterial Vaginosis in Late Third Trimester to Prevent Maternal Peripartum Infection,A Randomized Controlled Trial of Treatment of Bacterial Vaginosis
NCT04580927,2024-03-22,"March 15, 2021",November 2025,August 2024,2020-10-02,NA,Interventional,Not Applicable,221,"Active, not recruiting",Improving Cardiovascular Health in New Mothers: Multi-Centre Open-Label Randomized Trial of a Breastfeeding Intervention to Improve Breastfeeding Practices and Lower Blood Pressure in Women With Hypertensive Disorders of Pregnancy,Breastfeeding and Postpartum Cardiovascular Health
NCT04587050,2022-08-04,"July 19, 2021",December 2023,July 2023,2020-10-07,NA,Observational,NA,80,Recruiting,Screening for Human Papillomavirus and Cervical Cancer in Young Women With Perinatally Acquired HIV,Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV
NCT04624568,2023-06-14,"November 17, 2020","May 17, 2023","May 17, 2023",2020-11-05,NA,Interventional,Not Applicable,81,Completed,Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance.,Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance
NCT04629001,2020-11-12,"September 1, 2020","December 1, 2021","September 1, 2021",2020-11-12,NA,Observational [Patient Registry],NA,1000,Unknown status,Effect of Covid-19 on Outcomes of Pregnancy,Effect of Covid-19 on Outcomes of Pregnancy
NCT04679675,2023-09-06,"November 20, 2020","July 29, 2023","July 29, 2022",2020-12-09,2023-07-19,Interventional,Not Applicable,32771,Completed,Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer: the STEP Trial,Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04680325,2020-12-21,"July 1, 2017","August 31, 2018","November 15, 2017",2020-12-16,NA,Interventional,Not Applicable,23,Completed,Impact of Cranberry Juice Consumption on Gut and Vaginal Microbiota in Post-menopausal Women,Impact of Cranberry Juice Consumption on Gut and Vaginal Microbiota in Post-menopausal Women
NCT04694495,2021-08-02,"November 12, 2020","December 12, 2022","December 11, 2021",2021-01-03,NA,Observational,NA,10000,Unknown status,HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study,HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
NCT04699578,2021-01-05,"December 28, 2020","May 1, 2022","December 31, 2021",2021-01-01,NA,Observational,NA,230,Unknown status,Impact of COVID-19 Infection on the Course of Pregnancy and Fetal-neonatal Outcomes,COVID-19 Infection and Fetal-neonatal Outcomes
NCT04704908,2023-01-24,"February 6, 2021",December 2023,"April 1, 2021",2021-01-07,NA,Observational,NA,979,"Active, not recruiting","Immuno-persistence Study of A Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Female Subjects Aged 9 to 17 Years",Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)
NCT04709601,2024-02-02,"January 4, 2021",December 2024,December 2024,2020-12-17,NA,Interventional,Phase 4,20,Recruiting,Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in the Management of Recurrent Urinary Tract Infections in Women,Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.
NCT04718220,2023-11-27,"March 1, 2021",August 2024,August 2024,2021-01-16,NA,Interventional,Not Applicable,420,"Active, not recruiting","Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19","Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19"
NCT04719754,2021-01-18,"June 1, 2021",December 2022,October 2022,2021-01-18,NA,Observational,NA,164,Unknown status,Epidemiology and Clinico-investigative Study of Abnormal Vaginal Discharge During Pregnancy,Epidemiology of Abnormal Vaginal Discharge During Pregnancy
NCT04723069,2023-04-01,"September 21, 2021","March 11, 2022","March 11, 2022",2021-01-22,NA,Interventional,Phase 2,198,Completed,"A Randomized, Double-blind, Positive-Controlled Study to Evaluate the Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases",Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
NCT04753502,2021-02-09,"September 1, 2005","November 30, 2020","July 1, 2020",2021-02-02,NA,Observational,NA,63,Completed,Laparoscopic Treatment for Appendicitis During Pregnancy: Retrospective Cohort Study,Laparoscopic Treatment for Appendicitis During Pregnancy
NCT04763486,2021-02-20,"March 1, 2021","March 1, 2023","March 1, 2022",2019-07-29,NA,Interventional,Not Applicable,2500,Unknown status,Prophylactic Antibiotic Treatment for Perineal Tear After Delivery: a Randomized Controlled Trial,Prophylactic Antibiotic After Perineal Tear
NCT04769167,2023-12-04,"February 1, 2021",December 2027,"February 20, 2024",2021-02-14,NA,Interventional,Not Applicable,1500,"Active, not recruiting",Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes,Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
NCT04778722,2022-11-14,"August 15, 2022","May 1, 2023","April 1, 2023",2021-02-23,NA,Interventional,Not Applicable,44,Recruiting,Development of Microbiome Vaginae After Use of Oral Probiotics in First the Trimester of Pregnancy. A Prospective Pilot Study,Microbiome Vaginae After Use of Oral Probiotics in Pregnancy.
NCT04792710,2021-03-08,"March 8, 2021","June 30, 2022","March 31, 2022",2021-03-08,NA,Interventional,Phase 4,1000,Unknown status,Randomised Trial Comparing Pre-operative Administration of Single Dose Kefazolin to Kefazolin Plus Metronidazole to Reduce Postpartum Infection,Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection
NCT04807894,2023-10-20,"November 1, 2020","December 31, 2024","August 31, 2024",2020-10-19,NA,Interventional,Phase 4,100,Recruiting,Prevention of Recurrent Urinary Tract Infection Using Vaginal Testosterone Versus Placebo,Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
NCT04823234,2021-09-26,"March 10, 2021","September 15, 2021","June 30, 2021",2021-03-26,NA,Observational,NA,40,Completed,"Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women - ""The PINK-CO Protocol""",Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women
NCT04825093,2023-03-19,"September 29, 2021","December 30, 2024","October 30, 2023",2020-12-02,NA,Interventional,Not Applicable,500,Recruiting,Randomised Clinical Trial of Vitamin D Supplementation in Pregnant Women and Prevalence of Covid-19 Immunity.,Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19
NCT04831086,2022-05-11,"May 5, 2021","December 30, 2023","September 30, 2023",2021-03-24,NA,Interventional,Phase 3,340,Recruiting,To Optimize Antenatal Management of Women Admitted With Pre Term Labor and Intact Membranes Using Multivariable Prediction Models: Multicenter Randomised Control Trial (OPTIM-PTL),To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis
NCT04831840,2023-04-10,"May 26, 2021","June 1, 2024","June 1, 2024",2021-04-02,NA,Observational,NA,180,Recruiting,Is PCR Amplification More Sensitive Than Urine Cultures in Diagnosing Urinary Tract Infections in Patients With Recurrent Bladder Infections?,Recurrent Urinary Tract Infections and the Microbiome
NCT04832581,2021-04-01,"January 20, 2020","July 8, 2020","June 3, 2020",2021-04-01,NA,Interventional,Not Applicable,67,Completed,"Effectiveness Of The Self-Care Behavior Development Program For Urinary Tract Infections in Pregnant, Women",Developing Self-care Behaviors for Urinary Tract Infections
NCT04836910,2023-12-03,"September 1, 2024","March 30, 2026","March 30, 2026",2021-03-25,NA,Observational,NA,40,Recruiting,The Change in Microbiome Following Treatment of Women With Polycystic Ovaries,Microbiome and Polycystic Ovaries
NCT04880343,2023-09-27,"January 26, 2021","January 26, 2024","January 26, 2024",2021-04-29,NA,Interventional,Not Applicable,108,Suspended,"Randomised, Open-label, Controlled Clinical Trial to Evaluate the Efficacy of a Product Consisting of D Mannose 2 g+ Cran-max 500 mg+ Vitamin D3 0.001 mg (UROMANNOSA®) in Women With Recurrent Lower Urinary Tract Infections",Clinical Study to Evaluate the Efficacy of the Dietary Supplement UROMANNOSA® in Women With Recurrent Lower Urinary Tract Infections
NCT04895020,2024-04-15,"May 28, 2021",May 2026,"January 13, 2023",2021-05-17,NA,Interventional,Phase 3,1200,Recruiting,"Evaluating the Immunogenicity and Safety of 9-valent Human Papillomavirus(Type6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine in Chinese Females Aged 9 to 45 Years: A Phase 3, Open-label, Non-randomised Clinical Trial",Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
NCT04910802,2021-09-09,"May 3, 2021","December 31, 2027","December 31, 2025",2021-05-01,NA,Interventional,Phase 4,150000,Recruiting,Concomitant HPV Vaccination and HPV Screening for Rapid Elimination of HPV Infection and Cervical Cancer in Sweden,Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
NCT04936815,2022-12-22,"December 1, 2021","December 31, 2024","November 30, 2024",2021-06-15,NA,Interventional,Not Applicable,9000,Recruiting,Effectiveness of Echocardiographic Screening of Pregnant Women During Antenatal Care,Echocardiographic Screening of Pregnant Women During Antenatal Care
NCT04955717,2023-05-08,"February 24, 2021","January 31, 2023","January 31, 2023",2021-06-29,NA,Interventional,Not Applicable,500,Completed,The Diagnosis and Treatment of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Pregnant Women to Prevent Adverse Neonatal Consequences.,Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
NCT04959331,2023-12-05,"November 2, 2021","December 31, 2024","September 30, 2024",2021-07-05,NA,Interventional,Phase 4,1000,Recruiting,Clinical Effectiveness and Bacteriological Eradication of Three Different Short-course Antibiotic Regimens and Single-dose Fosfomycin for Uncomplicated Lower Urinary Tract Infections in Adult Women.,Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.
NCT04969445,2023-01-24,"March 30, 2021",January 2024,"July 27, 2023",2021-07-13,NA,Observational,NA,647,Recruiting,"The Durability of Protection Study of A Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Women Aged 18 to 45 Years",The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
NCT04987164,2023-03-01,"November 18, 2021","August 4, 2022","August 4, 2022",2021-07-19,NA,Observational,NA,80,Completed,"Observational Study Evaluating the Number of Symptomatic Cystitis-like Episodes and Urinary Comfort of Women Consuming Cranberry, Cinnamon and Probiotic Strain Extracts","Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics"
NCT04992104,2023-04-19,"February 22, 2023",December 2024,December 2024,2021-06-16,NA,Observational,NA,800,Recruiting,Elucidating the Dynamics and Impact of the Gut Microbiome on Maternal Nutritional Status During Pregnancy,Microbiome and Malnutrition in Pregnancy
NCT04998318,2024-01-09,"November 28, 2022",April 2024,April 2024,2021-08-02,NA,Interventional,Not Applicable,400,Recruiting,Compare the Performance of the Pocket Colposcope to VIA/VILI for Triage of HPV+ Women in Kenya,1:1 Comparison of the Pocket Colposcope in Kenya
NCT05015400,2022-05-02,"September 5, 2021","January 1, 2022","December 15, 2021",2021-08-09,NA,Interventional,Not Applicable,13,Completed,Female Urogenital Nutrition- Health Study,Female Urogenital Nutrition- Health Study
NCT05022212,2024-02-22,"May 10, 2021","March 31, 2023","March 31, 2023",2021-05-07,NA,Interventional,Phase 2,45,Completed,"Phase 2 Placebo-controlled Randomized Trial of LACTIN-V (Lactobacillus Crispatus CTV-05) Among Women at High Risk of HIV Acquisition in Durban, South Africa",Phase 2 Trial of LACTIN-V in Women at High Risk of HIV Acquisition
NCT05023954,2021-08-20,"October 12, 2020","September 1, 2022","April 1, 2022",2021-08-10,NA,Observational,NA,330,Unknown status,mSEP: Investigation of Maternal Immunity and Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis,mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis
NCT05027776,2024-04-15,"September 15, 2021","September 29, 2026","November 22, 2023",2021-08-20,NA,Interventional,Phase 3,1348,Recruiting,"Evaluating the Immunogenicity and Safety of Quadrivalent Human Papillomavirus Recombinant Vaccine (Type 6, 11, 16, 18) in Healthy Chinese Female Subjects Aged 9 to 26 Years: A Phase 3, Open-label, Non-randomized Clinical Trial",Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
NCT05040334,2022-03-24,"January 1, 2021","May 1, 2022","April 1, 2022",2021-08-14,NA,Interventional,Phase 4,138,Unknown status,Role of Prophylactic Antibiotics in Preventing Pelvic Infection After Surgical Evacuation,Role of Prophylactic Antibiotics in Preventing Pelvic Infection After Surgical Evacuation
NCT05044156,2022-03-06,"October 21, 2021","March 6, 2022","March 6, 2022",2021-09-04,NA,Observational [Patient Registry],NA,90,Completed,Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women,Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
NCT05045755,2023-01-24,"April 13, 2021",January 2024,"August 10, 2023",2021-07-13,NA,Observational,NA,1339,Recruiting,"The Durability of Protection and Immuno-persistence Study of A Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Women Aged 18 to 45 Years",The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
NCT05055388,2021-09-14,"December 3, 2020","May 31, 2022","December 31, 2021",2021-09-14,NA,Observational,NA,160,Unknown status,Epidemiological Investigation of Sepsis in Obstetrics Admitted to ICU From 2008 to 2016 in Beijing China: A First Multicenter Report,Epidemiological Investigation of Sepsis in Obstetrics Admitted to ICU
NCT05059015,2021-11-29,"May 1, 2019","December 3, 2022","September 24, 2020",2021-08-12,NA,Interventional,Not Applicable,80,Unknown status,Effect of HPV Self-collection in Adherence to Cervical Cancer Screening Algorithms,Human Papilloma Virus (HPV) Self-collection and Women Adherence
NCT05085353,2024-03-26,"February 25, 2020","February 25, 2025","February 25, 2025",2021-10-07,NA,Observational [Patient Registry],NA,50,Enrolling by invitation,Fetal Outcomes Among Pregnant Emergency General Surgery Patients: a Prospective Multi-center Evaluation of Pregnant Patients Undergoing Emergency General Surgery,Fetal Outcomes Among Pregnant Emergency General Surgery Patients
NCT05089175,2021-12-01,"November 30, 2021","December 30, 2024","December 30, 2023",2021-10-11,NA,Observational [Patient Registry],NA,4500,Recruiting,The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population,The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
NCT05108675,2023-07-19,"November 24, 2021","June 30, 2024","June 30, 2024",2021-09-22,NA,Observational,NA,400,"Active, not recruiting",Elucidating the Dynamics and Impact of the Gut Microbiome on Maternal Nutritional Status During Pregnancy,Microbiome and Malnutrition in Pregnancy (MMiP)
NCT05124327,2023-02-06,"March 7, 2022","June 30, 2022","June 30, 2022",2021-10-01,NA,Interventional,Not Applicable,30,Completed,Compliance and Satisfaction With a Remote Postpartum Vital Sign Monitoring and Follow-up Program for Hypertensive Disorders of Pregnancy (HDP) for 10 Days Postpartum,Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy
NCT05127252,2023-05-26,"April 10, 2023","December 30, 2026","March 10, 2026",2021-11-09,NA,Observational [Patient Registry],NA,500,Recruiting,Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive,Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive
NCT05138822,2023-10-19,"May 18, 2022","July 16, 2024","July 16, 2024",2021-11-15,NA,Interventional,Phase 1,80,Suspended,"A Double-Blind, Double Dummy, Randomized, Phase 1b, Nitrofurantoin Controlled, Repeat Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Microbiological Response of GSK3882347 in Female Participants With Acute Uncomplicated Urinary Tract Infection","Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections"
NCT05140941,2024-04-04,"April 4, 2022",December 2025,December 2024,2021-11-05,NA,Interventional,Phase 4,100,Recruiting,"Safety, Tolerability, and Outcomes of Velpatasvir/SofosbuviR in Treatment of Chronic Hepatitis C Virus During Pregnancy (STORC)",Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
NCT05159726,2023-01-30,"July 5, 2022","December 31, 2022","August 20, 2022",2021-12-08,NA,Interventional,Not Applicable,200,Completed,YOU MATTER: Using Video Education to Improve Patient Knowledge of Severe Maternal Morbidity (SMM) Warning Signs,Postpartum Video Education
NCT05160649,2023-04-27,"October 10, 2021",October 2023,June 2023,2021-12-15,NA,Observational,NA,50,"Active, not recruiting","Effect of Time of COVID 19 Infection on Fetomaternal Outcome, and Immunological Changes During the Disease Course",Effect of Covid 19 Infection on Fetomaternal Outcome
NCT05197621,2024-01-11,"April 13, 2020","May 5, 2025","May 5, 2024",2022-01-14,NA,Observational,NA,300,Recruiting,The Impact of COVID-19 on Maternal and Neonatal Outcomes,The Impact of COVID-19 on Maternal and Neonatal Outcomes
NCT05206500,2024-04-09,"May 17, 2022",June 2026,December 2025,2022-01-07,NA,Interventional,Phase 4,100,Recruiting,Clinical Implication of Next Generation Sequencing of Urinary Bacteria in Patients With Low Colony Forming Units of Bacteria in Traditional Urine Culture,NextGen - Clinical Implication of Next Generation Sequencing
NCT05210348,2022-01-21,"September 15, 2021","May 1, 2022","February 1, 2022",2022-01-07,NA,Observational,NA,1000,Unknown status,Clinical Evaluation Study of Urine hrHPV Detection for the Diagnosis of Presence of Cervical HPV and Correlation of Cervical Lesions,Clinical Evaluation of Detection of High Risk HPV in Urine
NCT05227937,2023-09-19,"September 21, 2022","December 31, 2024","December 31, 2024",2022-01-27,NA,Observational,NA,75,Recruiting,Single Dose Amikacin for Uncomplicated Cystitis in the Emergency Department (ED): A Feasibility Study,Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
NCT05234112,2024-02-21,"September 15, 2022","January 31, 2024","December 30, 2023",2022-01-03,NA,Interventional,Not Applicable,30000,Completed,Prevention and Screening Intervention Project - Towards Elimination of Cervical Cancer,Prevention and Screening Towards Elimination of Cervical Cancer
NCT05242172,2022-02-15,"January 15, 2022","February 28, 2022","February 15, 2022",2022-02-15,NA,Observational,NA,127,Unknown status,THE RELATIONSHIP OF CRP/ALBUMIN RATIO LEVEL AND PROGNOSIS IN PREGNANT COVID-19 PATIENTS,THE RELATIONSHIP OF CRP/ALBUMIN RATIO LEVEL AND PROGNOSIS IN PREGNANT COVID-19 PATIENTS
NCT05244967,2023-11-28,"November 11, 2020","June 30, 2029","December 31, 2028",2022-01-27,NA,Observational,NA,533,Recruiting,Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility,Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
NCT05254808,2022-02-27,"September 6, 2021","February 14, 2022","February 14, 2022",2022-02-14,NA,Interventional,Phase 3,13,Terminated,EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care,EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care
NCT05275257,2023-09-11,April 2022,April 2028,April 2026,2022-01-31,NA,Interventional,Not Applicable,0,Withdrawn,"Can the Use of Uricap Female, a New Urine Collecting Device, Lead to Better Care for Women > 75+Years With Urinary Incontinence?",Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years?
NCT05282095,2023-06-28,"June 1, 2022","May 31, 2025","May 31, 2025",2022-03-07,NA,Observational,NA,300,Recruiting,Effect of HPV Integration on Prognosis of Young Women With CIN2 in China: A Multi-center Cohort Study in China,Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
NCT05283239,2023-11-15,"January 1, 2022","December 31, 2024","November 30, 2024",2022-02-17,NA,Observational,NA,1000,Recruiting,Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection：a Multi-center Cohort Study in China,Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection
NCT05309122,2022-03-25,"March 19, 2022","March 19, 2025","March 19, 2024",2022-03-25,NA,Observational,NA,10000,Recruiting,A Retrospective Cohort Study on the Effectiveness of Various Screening Strategies for Uterine Cervical Cancer,Cervical Cancer Screening Strategies
NCT05318144,2022-04-06,"June 1, 2021","February 1, 2022","December 1, 2021",2022-04-06,NA,Observational [Patient Registry],NA,228,Completed,Prognostic Value of Serum Melatonin as a Biomarker for the Determination of Severe COVID-19 Infection in Pregnant Women,Melatonin Levels on COVID-19 Positive Pregnant Women
NCT05334706,2023-05-08,"September 13, 2022",May 2024,May 2024,2022-04-05,NA,Interventional,Phase 2,69,Recruiting,"A Non-Randomized, Open-Label Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV16/18-Positive Women After Vaccination With 9vHPV, a Multivalent L1 Virus-like Particle Vaccine, Evaluated in Cervical, Anal and Oral Samples Obtained After One, Two, and Three Vaccine Doses (RIFT-HPV1/RIFT-HPV2)",A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
NCT05340322,2023-11-29,"May 1, 2022","October 15, 2023","April 15, 2023",2022-04-11,NA,Interventional,Not Applicable,497,Completed,"Closing the Gap Between Identification and Treatment of Cervical Abnormalities in Lima, Perú Through Integraton of Pocket Colposcopy, Telemedicine and Visual Counseling",Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine
NCT05341284,2022-04-24,"August 1, 2022","August 1, 2027","August 1, 2027",2022-03-29,NA,Observational,NA,12118,Not yet recruiting,Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS): A Prospective Cohort,Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS)
NCT05362955,2024-02-12,"April 26, 2023","August 1, 2024","August 1, 2024",2022-05-02,NA,Interventional,Phase 1,12,"Active, not recruiting",5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa,5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa
NCT05371353,2024-04-15,"May 14, 2022",May 2027,May 2027,2022-05-04,NA,Observational,NA,600,Recruiting,"Evaluating the Immune Persistence of Recombination Quadrivalent HPV Vaccine (Type 6, 11, 16, 18) in Healthy Chinese Female Subjects Aged 9 to 45 Years: A Phase 3, Open-label, Non-randomized Clinical Trial",Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
NCT05372016,2023-11-22,"September 19, 2020","June 17, 2022","June 17, 2022",2020-12-27,NA,Interventional,Phase 3,1200,Completed,"A Randomized, Double-Blind and Positive-Controlled Phase 3 Study to Evaluate the Immunogenicity and Safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged16-26 Years",Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
NCT05383521,2023-05-04,"December 1, 2023","December 30, 2023","December 30, 2023",2021-01-05,NA,Interventional,Not Applicable,20,Not yet recruiting,Oral Tinidazole Treatment of Refractory Trichomonas Vaginitis,Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis
NCT05397782,2024-03-06,"September 26, 2022","February 21, 2024","February 21, 2024",2022-05-26,NA,Interventional,Not Applicable,14,Completed,Pilot Study: Effects of Flourish Vaginal Care System in Women With Recurrent Symptomatic Urinary Tract Infections,Effects of Flourish on Recurrent Urinary Tract Infection
NCT05408624,2024-03-20,"July 15, 2022","December 1, 2024","June 30, 2024",2022-05-23,NA,Observational,NA,60,Recruiting,Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses,Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
NCT05413811,2024-04-12,"March 22, 2023","December 31, 2025","December 31, 2025",2022-06-07,NA,Interventional,Not Applicable,180,Recruiting,Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV,Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
NCT05414305,2023-10-11,"October 1, 2020",December 2023,December 2023,2022-05-26,NA,Interventional,Phase 2,29,"Active, not recruiting",The Female Microbiome in Patients Undergoing Bladder Instillation Therapy,The Female Microbiome in Patients Undergoing Bladder Instillation Therapy
NCT05415865,2022-09-21,"September 12, 2022","May 1, 2024","April 1, 2024",2022-06-08,NA,Interventional,Phase 3,50,Recruiting,"The Effect of Intravesical Lidocaine Solution Versus Placebo as Anesthesia Prior to Intravesical Injection of Onabotulinum Toxin A. A Randomized, Double-blind, Placebo Controlled Cross-over Study",The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder
NCT05426148,2022-06-22,"May 1, 2020","April 30, 2021","August 1, 2020",2022-06-15,NA,Interventional,Phase 4,540,Completed,A Study to Assess the Immunogenicity Consistency of Three Consecutive Batches of Commercial-scale of Recombinant Human Papillomavirus(HPV) Bivalent Vaccine (Escherichia Coli) in Healthy Female Subjects Aged 9-14 Years,Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
NCT05429346,2023-03-13,"January 8, 2023","April 30, 2026","January 31, 2025",2022-06-17,NA,Observational,NA,339000,Recruiting,Comparative Effectiveness of Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity (SMM),Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity
NCT05435430,2022-06-26,"September 1, 2022","March 1, 2024","September 30, 2023",2022-06-26,NA,Observational,NA,150,Recruiting,Post-COVID-19 Infection and Reproductive Health in Women Undergoing I.V.F. Treatment,COVID-19 Infection and Reproductive Health in Infertile Women
NCT05453006,2024-01-30,"February 20, 2023","May 31, 2025","May 19, 2024",2022-07-06,NA,Interventional,Not Applicable,5680,Recruiting,Reducing Cervical Cancer Screening Disparities in Somali Immigrant Women Through a Primary Case-based HPV Self-sampling Intervention,HPV Self-Sampling in Somali Women
NCT05460546,2022-07-13,"January 19, 2021","November 30, 2021","November 30, 2021",2022-07-13,NA,Interventional,Phase 2,180,Completed,"A Multicenter, Randomized, Double-blind, Dose-parallel, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of Jincaopian Tablets in Subjects With Chronic Pelvic Pain After Pelvic Inflammatory Disease",The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
NCT05469984,2022-07-19,September 2022,September 2025,September 2024,2022-07-09,NA,Interventional,Not Applicable,200,Not yet recruiting,Comparing Obstetrical Outcomes and Infectious Morbidity Between Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor,Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor
NCT05472779,2024-01-05,"January 3, 2023","January 1, 2025","July 31, 2024",2022-07-21,NA,Interventional,Phase 2,108,Recruiting,Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections: TAPER (Techniques of APplying Vaginal Estrogen for Prevention of Recurrent Urinary Tract Infections) Trial,Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections
NCT05477953,2024-04-11,"August 17, 2022","March 31, 2032","March 31, 2032",2022-05-19,NA,Observational,NA,50,"Active, not recruiting","Observational Pregnancy Safety Study of Women Exposed to Nifurtimox During Pregnancy to Describe the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant",An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health
NCT05488340,2023-12-15,"July 13, 2022",December 2025,June 2025,2022-08-02,NA,Interventional,Phase 2,318,Recruiting,"A Phase 2, Double-blind, Randomized, Active-controlled Evaluation of the Safety, Tolerability, Pharmacokinetics and Efficacy of LBP-EC01 in the Treatment of Acute Uncomplicated Urinary Tract Infection Caused by Drug Resistant E. Coli",A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
NCT05509413,2023-01-24,"November 8, 2022",November 2024,May 2024,2022-08-18,NA,Interventional,Not Applicable,168,Recruiting,DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections,DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections
NCT05510830,2022-09-07,October 2022,January 2030,January 2028,2022-08-16,NA,Interventional,Not Applicable,250,Not yet recruiting,A Study of the Value of Diagnostic Cervical Conization for Persistent Infection or Integration of Human Papillomavirus,Diagnostic Cervical Conization for Persistent Infection or Integration of HPV
NCT05520684,2022-08-29,"February 15, 2022","January 1, 2023","November 1, 2022",2022-08-26,NA,Observational,NA,120,Recruiting,Urinary Tract Infection Risk in Women With Asymptomatic Bacteriuria or Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors,"Asymptomatic Bacteriuria, Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors and UTI Risk"
NCT05537519,2024-03-25,"May 1, 2023","June 30, 2024","July 28, 2023",2022-09-09,NA,Interventional,Phase 1/Phase 2,1,"Active, not recruiting",Phage Therapy for the Treatment of Urinary Tract Infection,Phage Therapy for the Treatment of Urinary Tract Infection
NCT05545137,2024-04-16,"September 29, 2022","February 20, 2024","February 5, 2024",2022-09-02,NA,Interventional,Phase 3,299,Completed,"Pivmecillinam Hydrochloride Tablets Versus Fosfomycin Tromethamine Granules for Uncomplicated Urinary Tract Infection in Women -A Randomized, Double-blind, Double Simulation, Positive Drug Parallel-controlled, Multi Center Phase III Clinical Trial in China",Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection
NCT05545514,2023-11-22,"March 15, 2023","January 31, 2025","July 31, 2024",2022-09-14,NA,Interventional,Phase 4,220,Recruiting,Individualized Homeopathy to Reduce the Use of Antibiotics in Women With Recurrent Uncomplicated Urinary Tract Infections EudraCT:2021-002214-14,Individualized Homeopathy to Reduce the Use of Antibiotics in Women With Recurrent Uncomplicated Urinary Tract Infections
NCT05551949,2023-10-17,"January 31, 2023","August 31, 2025","August 31, 2025",2022-09-20,NA,Interventional,Phase 4,50,Enrolling by invitation,Mechanisms of Successful Vaginal Estrogen Prophylaxis for Postmenopausal Women With Recurrent Urinary Tract Infections: Urogenital Microbiota and Host Immune Responses,Preventing Recurrent UTI With Vaginal Estrogen
NCT05553652,2022-09-21,"September 19, 2022","December 1, 2027","August 1, 2024",2022-09-16,NA,Interventional,Not Applicable,720,Recruiting,"The Effect of ASTARTE™; Lactobacillus Crispatus, Lactobacillus Rhamnosus, Lactobacillus Jenesii and Lactobacillus Gasseri on the Reduction of Risk Factors for Recurrent Urinary Tract Infection in Women",The Effect of ASTARTE™ on Recurrent Urinary Tract Infection
NCT05554081,2022-09-21,"August 1, 2022","December 31, 2023","August 31, 2023",2022-09-21,NA,Interventional,Phase 3,200,Recruiting,Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Catch in the Detection of Asymptomatic Bacteriuria in an Obstetric Population,Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
NCT05557318,2024-04-08,"October 8, 2022",October 2025,September 2025,2022-09-21,NA,Interventional,Not Applicable,120,Recruiting,Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge,Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
NCT05570331,2022-10-05,"January 1, 2022","December 31, 2025","February 28, 2023",2022-10-05,NA,Observational,NA,2200,Recruiting,Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women：a Prospective Cohort Study,Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women
NCT05573334,2023-07-17,"July 10, 2023",September 2025,February 2025,2022-10-05,NA,Interventional,Not Applicable,40,Recruiting,Effects of Flourish HEC Vaginal Care System in Menopausal Women With Recurrent Urinary Tract Infections,Vaginal Care System for Menopausal Women With Urinary Tract Infections
NCT05580341,2022-10-26,"September 1, 2022",December 2023,June 2023,2022-10-11,NA,Interventional,Phase 3,1200,"Active, not recruiting","A Phase III, Randomized, Blinded, Positive-controlled Study to Compare the Immunogenicity of Zerun 9-valent Human Papillomarivus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Pichia Pastoris) in Healthy Female Subjects Aged 16-26 Years.",Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
NCT05584657,2023-10-25,"October 18, 2022",November 2023,November 2023,2022-10-14,NA,Interventional,Phase 3,2229,"Active, not recruiting","A Prospective, Phase 3, Randomized, Multi-center, Double-blind Study of the Efficacy, Tolerability, and Safety of Oral Sulopenem Etzadroxil/Probenecid Versus Oral Amoxicillin/Clavulanate for Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women",Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
NCT05585970,2022-10-18,"November 1, 2022","May 1, 2023","May 1, 2023",2022-10-16,NA,Interventional,Not Applicable,50,Not yet recruiting,Comparison of Procalcitonin Level in Normal Population and in Chronic Kidney Disease Patients Who Don't Have Infection,Comparison of Procalcitonin Level in Normal Population and in Chronic Kidney Disease Patients Who Don't Have Infection
NCT05587283,2023-03-07,"November 2, 2022",May 2023,April 2023,2022-10-17,NA,Interventional,Phase 1,24,Recruiting,"Phase 1 Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Multiple Ascending Dose Clinical Trial to Evaluate the Safety, Tolerability and Acceptability of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Female Volunteers","Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women"
NCT05590195,2024-01-05,"May 1, 2024","June 1, 2025","March 1, 2025",2022-10-06,NA,Interventional,Phase 3,50,Not yet recruiting,Effect of PreforPro® (Prebiotic and Bacteriophage) on Urinary and Vaginal Health,Effect of PreforPro® on Urinary and Vaginal Health
NCT05591742,2024-02-02,"October 1, 2021","October 1, 2025","October 1, 2024",2022-10-15,NA,Interventional,Not Applicable,100,Recruiting,"The Effect on Bacterial Composition in Urine, Vagina and Faces After Treatment With Lactobacilli and Its Influence on Recurrent Cystitis in Postmenopausal Women.",Bacterial Composition and Recurrent Cystitis in Postmenopausal Women After Treatment With Lactobacilli.
NCT05603624,2023-08-24,"September 2, 2021","September 1, 2022","September 1, 2022",2022-10-28,NA,Interventional,Not Applicable,163,Terminated,Effect of Sterile Versus Clean Gloves Intrapartum and Postpartum Infections at Term,Effect of Sterile Versus Clean Gloves Intrapartum and Postpartum Infections at Term
NCT05613283,2023-12-19,"November 19, 2022","August 31, 2027",July 2026,2022-11-04,NA,Observational,NA,17875,"Active, not recruiting",Primary Cervical Cancer Screening by Self-sampling HPV Test,Primary Cervical Cancer Screening by Self-sampling HPV Test
NCT05630833,2023-02-09,"January 11, 2023","October 9, 2023","September 11, 2023",2022-11-23,NA,Interventional,Phase 3,300,Recruiting,"A Phase III, Multicenter, Randomized, Active Reference, Double Blind, Double-dummy Study in Japanese Female Participants to Evaluate the Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)",A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)
NCT05632705,2022-11-21,"March 8, 2021","April 30, 2022","January 31, 2022",2021-03-08,NA,Interventional,Not Applicable,1000,Completed,A Randomised Trial to Evaluate the Efficacy and Feasibility of a Closing Pack to Reduce the Rate of Surgical Site Infection Following Caesarean Section,Efficacy of Using a Closing Pack to Reduce Postpartum Sepsis
NCT05648747,2022-12-09,"January 1, 2023","January 30, 2024","January 1, 2024",2022-12-09,NA,Observational,NA,300,Recruiting,Factors Associated With an Unfavorable Clinical Course in Hospitalized Patients With Pelvic Inflammatory Disease in Post Covid 19 Era: a Multicentric Retrospective Cohort Study,Pelvic Inflammatory Disease in COVID-19 Era
NCT05652374,2022-12-14,"October 20, 2022",October 2025,October 2025,2022-11-23,NA,Interventional,Phase 4,100,Recruiting,Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study,Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
NCT05655936,2023-07-05,"June 29, 2023","July 1, 2027","July 1, 2027",2022-12-08,NA,Interventional,Not Applicable,454,Recruiting,Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial,Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
NCT05666778,2023-04-28,"February 13, 2023","July 31, 2027","December 1, 2025",2022-12-19,NA,Interventional,Phase 2,402,Recruiting,Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs Through Reduced Harmful Sexual and Menstrual Practices,Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
NCT05667207,2023-11-14,"June 15, 2023","February 1, 2024","February 1, 2024",2022-12-19,NA,Interventional,Not Applicable,200,Recruiting,Dipsticks and Point-of-care Microscopy to Reduce Antibiotic Use in Women With Uncomplicated Urinary Tract Infections: a Cluster-randomized Controlled Pilot Trial,Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)
NCT05669911,2023-10-31,"August 28, 2022","December 31, 2023","November 6, 2023",2022-11-08,NA,Interventional,Not Applicable,235,"Active, not recruiting",Pilot Study: Evaluation of a Novel Self-Collection Device for Cervical Cancer Screening,Development of a Self-collection Device for Cervical Cancer Screening
NCT05670535,2023-01-03,"March 1, 2021","November 10, 2022","October 15, 2022",2023-01-02,NA,Observational,NA,118,Completed,Vaginal Infections and Sexual Dysfunction in Women With Primary Sjögren's Syndrome,Sjögren and Gynecologic Considerations
NCT05702762,2023-01-18,"October 1, 2022","June 30, 2024","June 30, 2023",2022-09-22,NA,Interventional,Phase 2,160,Recruiting,Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting,Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting
NCT05711901,2024-02-24,"January 1, 2022","June 30, 2024","June 1, 2024",2023-01-13,NA,Interventional,Not Applicable,80,Recruiting,Multicenter Observational Prospective Study of the Efficacy and Safety of Selective Lipopolysaccharide Hemosorption Using the Efferon LPS Device in Maternal Sepsis Complicated by Organ Dysfunction and/or Septic Shock,Selective Lipopolysaccharide Hemosorption in Maternal Sepsis
NCT05723601,2024-01-17,"January 12, 2024",January 2025,January 2025,2023-02-01,NA,Interventional,Phase 4,24,Recruiting,Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection (rUTI) in Post-menopausal Women: a Cross-over Randomized Controlled Trial,Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
NCT05726318,2024-02-05,"February 17, 2023",July 2024,June 2024,2023-01-19,NA,Interventional,Phase 4,70,Recruiting,A Randomized Pilot and Feasibility Study of a cultuRE-Directed Approach to Urinary traCT Infection Symptoms in Older womeN: a Mixed Methods Evaluation - the REDUCTION Trial,Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women
NCT05730387,2023-05-31,"April 14, 2022","September 30, 2024","October 31, 2023",2022-12-09,NA,Observational,NA,6700,Recruiting,"Smart Discharges for Mom & Baby: Saving Mother-newborn Dyads by Developing a Predictive Risk Model to Identify Vulnerable Dyads and Guide Delivery of Evidence-based, Locally-informed Interventions for Targeted Post-discharge Care",Smart Discharges for Mom & Baby
NCT05730998,2023-02-15,"September 1, 2022","January 31, 2023","December 31, 2022",2023-02-07,NA,Interventional,Not Applicable,60,Completed,The Beneficial Effects of a Cranberry-based Oral Nutritional Supplement on the Prevention of Urinary Tract Infections in Diabetic Subjects,Cranberry for the Prevention of Urinary Tract Infections
NCT05762016,2023-03-07,"January 1, 2018","October 31, 2024","October 31, 2024",2023-02-22,NA,Observational,NA,30,"Active, not recruiting",A Comparison of the Outcomes of a Novel Technique of Mini- Incision and Self-Express (MISE) for Breast Abscess With the Conventional Techniques: A Retrospective Comparative Cohort Study,Outcomes of a Novel Technique of Mini- Incision and Self-Express (MISE) for Breast Abscess
NCT05783167,2023-12-06,"May 29, 2023","February 28, 2024","November 23, 2023",2023-03-13,NA,Observational,NA,502,Recruiting,Self-collected Cervical Cancer Screening Samples for Detection of Human Papillomavirus in HIV-positive Women - a Pilot Study of Self-collected Vaginal and Urine Samples,Self-collected Vaginal and Urine Samples in HIV-positive Women
NCT05788991,2023-03-28,"July 26, 2021","August 25, 2022","August 25, 2022",2023-03-15,NA,Interventional,Phase 4,151,Terminated,Comparative Study of the Efficacy and Safety of Vaginally Applied Dequalinium Chloride (10 mg) and Orally Applied Metronidazole (2 x 500 mg) in the Treatment of Bacterial Vaginosis,Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis
NCT05793814,2023-03-20,"May 7, 2021",June 2023,June 2023,2023-03-02,NA,Interventional,Not Applicable,130,Recruiting,"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Consumption of a Limosilactobacillus Supplement on Recurrence of Uncomplicated Symptomatic Urinary Tract Infections (UTI) in Healthy Women During a 6-month Period",Assess the Effects of a Limosilactobacillus Supplement on Recurrence of UTI in Healthy Women During a 6-month Period
NCT05793970,2023-03-30,"March 25, 2022","June 1, 2023","March 23, 2023",2023-03-19,NA,Observational,NA,450,Recruiting,Evaluation of IL-6 Levels on Umbilical Cord,IL6 on Umbilical Cord (Evaluation of IL-6 Levels on Umbilical Cord)
NCT05796921,2023-04-06,"January 2, 2023","March 30, 2024","December 29, 2023",2023-03-21,NA,Interventional,Not Applicable,200,Recruiting,"Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota: a Randomized, Double-blind, Placebo-controlled Clinical Trial",Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota
NCT05813184,2023-04-02,"April 30, 2023","October 30, 2025","April 30, 2025",2023-04-02,NA,Observational,NA,82,Not yet recruiting,Effect of Prenatal Antibiotics on Breast Milk Immune Function and on the Development of Neonatal Intestinal Immune System: the Role of IgA,Prenatal Antibiotics and Breast Milk / Neonatal IgA
NCT05826925,2023-04-10,March 2025,August 2027,August 2027,2023-04-10,NA,Interventional,Not Applicable,40,Not yet recruiting,Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy,Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
NCT05837962,2023-04-27,"April 10, 2023","December 28, 2023","August 16, 2023",2023-04-02,NA,Interventional,Not Applicable,60,Recruiting,"Feasibility and Acceptability of the Nursing Intervention ""EducaTHE"" to Improve Knowledge and Self-care Behaviors in the Face of Hypertensive Disorders of Pregnancy in Pregnant Women.",Nursing Intervention for Knowledge and Self-care Behaviors in the Face of Hypertensive Disorders of Pregnancy
NCT05895162,2023-06-12,"June 10, 2023","January 7, 2025","December 31, 2024",2023-05-15,NA,Interventional,Not Applicable,76,Recruiting,Randomized Controlled Trial to Assess the Effectiveness of a Zinc-containing Vaginal Gel and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis.,Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.
NCT05895578,2024-01-15,"June 21, 2023",November 2024,September 2024,2023-05-19,NA,Interventional,Not Applicable,90,Recruiting,"Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of a Probiotic on the Urinary Tract Microbiota in Women With Recurrent Urinary Tract Infections (rUTI).",Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection.
NCT05907187,2023-06-07,"November 7, 2017","June 9, 2020","November 21, 2018",2023-06-07,NA,Interventional,Not Applicable,100,Completed,"Intervention to Promote Cervical Cancer Prevention and Early Detection, and Understand the Role of Plants in HPV. (Research in Ethno-Medicine and Education)",Research in Ethno-Medicine and Education (REMED)
NCT05908682,2023-06-08,"July 28, 2022","October 31, 2029","October 31, 2029",2023-06-08,NA,Observational [Patient Registry],NA,100,Recruiting,"A Single-arm Safety Study of Subjects Exposed to Ibrexafungerp Whilst Pregnant, Including Infant Outcomes Up to One Year",Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
NCT05913180,2023-06-21,"June 15, 2023","August 15, 2025","August 15, 2025",2023-06-10,NA,Interventional,Phase 2,180,Not yet recruiting,Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries: a Randomized Double-blinded Controlled Trial,Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries
NCT05929963,2023-06-24,"May 9, 2023","January 1, 2025","February 20, 2024",2023-05-08,NA,Observational,NA,300,Enrolling by invitation,Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy,Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy
NCT05958953,2023-07-14,September 2023,"November 12, 2025",October 2025,2023-06-06,NA,Interventional,Phase 3,1400,Not yet recruiting,"PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes: a Phase III, Open-label, Randomized Controlled Multicentric Trial",PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes
NCT05966649,2023-12-13,"March 16, 2023",June 2028,December 2027,2023-03-02,NA,Interventional,Not Applicable,402,"Active, not recruiting",Synbiotics in Patients at RIsk fOr Preterm Birth: a Multi-center Double-blind Randomized Placebo-controlled trIal,Synbiotics in Patients at RIsk fOr Preterm Birth
NCT05970783,2023-07-29,"November 8, 2022",November 2024,February 2024,2023-07-13,NA,Interventional,Phase 3,414,Recruiting,"A Multicenter, Randomized, Double-blind, Dose-parallel, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Jincaopian Tablets in Subjects With Chronic Pelvic Pain After Pelvic Inflammatory Disease",A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease
NCT05990270,2023-08-05,"August 15, 2023","December 30, 2023","September 30, 2023",2023-07-28,NA,Interventional,Not Applicable,102,Recruiting,"The Effect of Education Given to Women on Knowledge, Attitudes and Beliefs on Cervical Cancer","The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief"
NCT05995106,2023-12-15,"October 2, 2023",June 2027,August 2026,2023-08-09,NA,Interventional,Not Applicable,580,Recruiting,Prospective Validation of Usefulness in the Hypertensive Disorder of Pregnancy With Cardiovascular Disease Management Solution Based on Interconnection to Hospital Examination,mHealth for Hypertensive Disorder of Pregnancy
NCT05999851,2023-08-17,September 2023,September 2031,May 2026,2023-06-15,NA,Interventional,Not Applicable,400,Not yet recruiting,Multiparametric Assessment of Maternal Vascular Function as a New Diagnostic and Prognostic Tool for Hypertensive Disorders of Pregnancy and Preeclampsia - EDIPE Study,Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
NCT06002126,2023-08-14,"August 2, 2023","November 1, 2025","December 1, 2024",2023-08-14,NA,Interventional,Not Applicable,1000,Recruiting,Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries,Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
NCT06015854,2023-08-23,"March 23, 2021","April 1, 2024","February 6, 2024",2023-08-23,NA,Interventional,Phase 2,18,Recruiting,"A Phase II Study to Determine the Efficacy and Safety of Vvax001, a Therapeutic Semliki Forest Virus Based Cancer Vaccine, in Patients With HPV-16 Induced Grade 3 Cervical Intraepithelial Neoplasia",Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II
NCT06019715,2023-08-30,"June 1, 2023","July 1, 2024","March 1, 2024",2023-08-24,NA,Interventional,Not Applicable,20,"Active, not recruiting",Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy,Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy
NCT06035601,2024-03-15,"March 7, 2024","June 15, 2026","June 15, 2025",2023-09-06,NA,Interventional,Not Applicable,100,Recruiting,An EHR-integrated Texting Platform to Promote Self-management in Women With Recurrent Urinary Tract Infections,EHR-integrated rUTI Texting Platform
NCT06049693,2024-03-28,"January 1, 2023","January 1, 2024","January 1, 2024",2023-04-25,NA,Interventional,Phase 4,156,Completed,Iron Prehabilitation and Perioperative Infectious Diseases of Endometrial Cancer Patients,Iron Prehabilitation in Endometrial Cancer
NCT06050148,2023-09-15,"August 1, 2023","December 31, 2029","December 31, 2028",2023-08-29,NA,Interventional,Phase 2/Phase 3,100,Recruiting,Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections,Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
NCT06052033,2023-09-23,"September 11, 2023","September 1, 2024","August 10, 2024",2023-09-18,NA,Interventional,Not Applicable,40,Recruiting,The Effect of 5-aminolaevulinic Acid Photodynamic Therapy Versus C02 Laser in the Treatment of Persistent Cervical Low-grade Squamous Intraepithelial Lesions With High-risk HPV Infection:A Non-randomized Controlled Trail Study,Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
NCT06056947,2023-09-25,"July 20, 2020","August 26, 2021","May 6, 2021",2023-09-13,NA,Interventional,Phase 3,577,Completed,"Phase III Study to Evaluate Efficacy and Safety of Different Formulations of Fenticonazole + Tinidazole + Lidocaine in the Treatment of Bacterial Vaginosis, Candidal Vulvovaginitis, Trichomonal Vaginitis and Mixed Infections",Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule
NCT06067386,2023-09-28,"October 15, 2023","October 15, 2024","October 15, 2024",2023-09-22,NA,Interventional,Not Applicable,3000,Not yet recruiting,Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs,Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs
NCT06069102,2024-02-28,"November 15, 2023","December 1, 2025","January 1, 2025",2023-09-28,NA,Interventional,Phase 4,60,Recruiting,OPT-BP: Optimal Blood Pressure Treatment Thresholds Following a Hypertensive Disorder of Pregnancy: A Pilot Trial,Optimal Blood Pressure Treatment Thresholds Postpartum
NCT06070454,2023-09-29,"November 14, 2023","November 14, 2025","November 14, 2025",2023-09-29,NA,Interventional,Not Applicable,91,Not yet recruiting,Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions,Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT06075264,2024-02-20,"December 6, 2023",December 2025,December 2024,2023-10-04,NA,Interventional,Phase 2,27,Recruiting,"A Phase II Double-blind, Placebo-controlled, Randomized Trial of Topical Artesunate Ointment for the Treatment of Patients With Vulvar High-grade Squamous Intraepithelial Lesions (Vulvar HSIL)","Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)"
NCT06091670,2023-10-16,"July 7, 2022","February 15, 2023","November 12, 2022",2023-10-16,NA,Observational,NA,881,Completed,Genital Hygiene Behaviors and Predicting Factors in Women Living in A Country: The Sample of Turkey,Genital Hygiene Behaviors and Predicting Factors
NCT06093035,2023-10-16,"November 10, 2023","December 31, 2024","May 31, 2024",2023-10-16,NA,Observational [Patient Registry],NA,60,Not yet recruiting,"Analysis of Urinary, Vaginal and Intestinal Microbiota in Patients With Neurogenic Bladder","Analysis of Urinary, Vaginal and Intestinal Microbiota in Patients With Neurogenic Bladder"
NCT06120205,2024-03-18,"November 15, 2023","June 1, 2024","May 1, 2024",2023-10-27,NA,Interventional,Not Applicable,870,Enrolling by invitation,SELF-CERV Pivotal Study: Method Comparison of Self-collection Using the Teal Wand Self-Collection Device and HCP (Health Care Provider) Cervical Collection for Detection of High-risk HPV (hrHPV) for Cervical Cancer Screening,SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
NCT06124820,2023-11-06,"October 1, 2023","October 1, 2026","October 1, 2025",2022-09-06,NA,Interventional,Not Applicable,48,Recruiting,"A Single-blinded, Randomised Controlled Trial Comparing the Use of Intravaginal Laser Therapy to Sham in Post-menopausal Women With Recurrent Urinary Tract Infections (rUTI) and the Impact on the Vaginal and Urinary Microbiome",RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women With Recurrent Urinary Tract Infections
NCT06131684,2023-11-09,November 2023,"June 30, 2024","June 30, 2024",2023-11-09,NA,Interventional,Early Phase 1,100,Not yet recruiting,Utility of Amniotic Fluid Analysis for Intrapartum Infection Prediction Model,Amniotic Fluid Analysis
NCT06131749,2023-11-08,"March 1, 2021","September 30, 2024","April 30, 2024",2023-11-08,NA,Observational,NA,603,"Active, not recruiting","Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa","Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa"
NCT06136702,2023-11-14,"December 7, 2022",December 2024,December 2024,2023-10-20,NA,Interventional,Not Applicable,1048,Recruiting,EarLy dEtection of cerVical cAncer in Hard-to-reach Populations of Women Through Portable and Point-of-care HPV TEsting Acceptability Study,ELEVATE Acceptability Study
NCT06137950,2023-11-14,"November 7, 2023","September 15, 2024","March 15, 2024",2023-11-07,NA,Interventional,Phase 1,90,Recruiting,Interferon Alpha Therapy for Cervical CIN I and HPV Infection,Interferon Alpha Therapy for Cervical CINI and HPV Infection
NCT06145724,2024-02-05,"January 2, 2024","September 30, 2026","August 31, 2026",2023-11-17,NA,Interventional,Not Applicable,24040,Enrolling by invitation,EnCoRe MoMS Aim 1: Develop and Implement a Community-informed Institutional Obstetric Sepsis Bundle,EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis
NCT06148532,2023-11-20,"April 26, 2023","September 30, 2026","August 31, 2025",2023-11-20,NA,Observational,NA,400000,Enrolling by invitation,EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis,EnCoRe MoMS:Engaging Communities to Reduce Morbidity From Maternal Sepsis
NCT06160349,2023-11-28,"July 20, 2023","September 30, 2026","August 31, 2026",2023-11-20,NA,Observational,NA,200,Enrolling by invitation,EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis,EnCoRe MoMS:Engaging Communities to Reduce Morbidity From Maternal Sepsis
NCT06177236,2023-12-19,"October 1, 2022","December 1, 2023","October 1, 2023",2023-11-22,NA,Interventional,Not Applicable,110,Completed,"The Effect of in Clinic or Self- Sampling for Cervical Cancer Screening on Status of Particitipation, Attitude and Anxiety.",Clinic or Self-Sampling for Cervical Cancer Screening
NCT06192966,2024-01-05,"January 1, 2018","March 31, 2022","March 31, 2022",2023-12-21,NA,Interventional,Not Applicable,106,Terminated,Efficacy of a Food Supplement for the Treament of Recurrent Urinary Tract Infections,Effect of Probiotics on Recurrent Urinary Tract Infections
NCT06231056,2024-01-20,"January 1, 2019","June 30, 2023","December 31, 2020",2024-01-20,NA,Interventional,Not Applicable,250,Completed,"Probiotic Therapy in Pregnancy for the Reduction of Streptococcus Agalactiae Positivity and the Frequency of PROM, pPROM and Preterm Birth",Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection
NCT06243666,2024-02-10,"February 20, 2024","December 31, 2026","December 31, 2026",2024-01-29,NA,Observational,NA,2188,Not yet recruiting,Long-term Effectiveness and Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Girls Aged 9-17 Years,Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
NCT06253169,2024-02-02,February 2024,June 2025,March 2025,2024-01-25,NA,Observational,NA,2000,Not yet recruiting,Benefit of Self-sampling for HPV DNA in a General Practitioner's Office to Improve Participation in Cervical Screening - The ASTRA Study.,HPV DNA Self-sampling in a General Practitioner's Office.
NCT06261736,2024-02-08,"October 24, 2023",May 2025,May 2025,2024-02-08,NA,Interventional,Not Applicable,70,Recruiting,The Effectiveness of Prophylactic Antibiotics for Urethral Bulking,The Effectiveness of Prophylactic Antibiotics for Urethral Bulking
NCT06268483,2024-02-13,"March 1, 2022","March 28, 2023","March 28, 2023",2024-02-13,NA,Interventional,Not Applicable,50,Completed,Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections,Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections
NCT06268509,2024-02-16,"April 1, 2023",August 2024,June 2024,2024-01-30,NA,Interventional,Not Applicable,245,Recruiting,Maternal Optimalization on Nutrition for Better Pregnancy Outcomes (MONAS Study),Nutrition Optimalization Among Pregnant Women to Improve Maternal and Neonatal Outcome in DKI Jakarta
NCT06273553,2024-02-15,March 2024,December 2027,October 2026,2024-01-31,NA,Interventional,Phase 1/Phase 2,39,Not yet recruiting,"An Open-Label, Phase 1/2 Study to Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of RG002 Injection (an mRNA Therapeutic Vaccine) in Subjects With Human Papillomavirus (HPV) 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 (CIN2/3)",A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3
NCT06281665,2024-04-02,"May 1, 2024","April 1, 2026","April 1, 2025",2024-02-15,NA,Interventional,Phase 4,60,Not yet recruiting,Treatment With Aspirin After Preeclampsia: TAP Trial,Treatment With Aspirin After Preeclampsia: TAP Trial
NCT06296615,2024-03-07,"April 1, 2021","October 30, 2022","October 30, 2022",2024-02-28,NA,Observational,NA,161,Completed,Whether Vaginal Microbiota Affects Pregnancy Outcomes After Embryo Transfer,Whether Vaginal Microbiota Affects Pregnancy Outcomes After Embryo Transfer
NCT06296901,2024-02-28,April 2024,October 2025,April 2025,2024-02-28,NA,Interventional,Not Applicable,600,Not yet recruiting,o Wipe or Not To Wipe?: That Is The Question,To Wipe or Not To Wipe?: That Is The Question
NCT06304610,2024-03-27,"May 1, 2024","December 31, 2024","December 31, 2024",2024-02-21,NA,Interventional,Not Applicable,200,Not yet recruiting,Hospital-based Validation of the New ELEVATE Screening Tool in Belgium and Ecuador,Hospital-based Validation of the New ELEVATE Screening Tool in Belgium and Ecuador
NCT06310720,2024-03-07,March 2024,December 2024,December 2024,2024-03-07,NA,Interventional,Not Applicable,150,Not yet recruiting,You Matter: Using Video Education to Improve Patient Knowledge of Severe Maternal Morbidity Warning Signs in High Risk Populations,Postpartum Video Education in High Risk Populations
NCT06314113,2024-03-10,"March 1, 2024","September 1, 2025","March 1, 2025",2024-03-10,NA,Observational,NA,50,Recruiting,Evaluation of Oral Epigallocatechin Gallate Treatment for Low-grade Cervical Lesions (L-SIL) Associated With Human Papilloma Virus (HPV) Infection,Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection
NCT06317688,2024-03-25,"November 6, 2023","August 14, 2024","August 14, 2024",2023-11-08,NA,Interventional,Phase 1,100,Enrolling by invitation,Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis,Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis
NCT06332781,2024-03-26,"August 1, 2024","July 31, 2025","June 1, 2025",2023-12-13,NA,Interventional,Phase 4,30,Not yet recruiting,Intravesical Gentamicin to Prevent Recurrent UTI,Intravesical Gentamicin to Prevent Recurrent UTI
NCT06344884,2024-03-27,May 2024,July 2025,July 2025,2024-03-27,NA,Interventional,Not Applicable,128,Not yet recruiting,Early Patient Removal of Urinary Catheters After Urogynecologic Surgery,Early Patient Removal of Urinary Catheters After Urogynecologic Surgery
NCT06352970,2024-04-03,"May 1, 2024","December 31, 2027","December 31, 2025",2024-03-20,NA,Observational,NA,500,Not yet recruiting,Effects of Tuberculosis Infection on Placental Development and Function,Effects of Tuberculosis Infection on Development and Function of the Placenta
NCT06353269,2024-04-05,April 2024,October 2027,January 2027,2024-02-28,NA,Interventional,Phase 4,111,Recruiting,Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections,Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
NCT06360965,2024-04-06,"January 1, 2024","December 31, 2026","March 31, 2026",2024-04-01,NA,Interventional,Not Applicable,102,Recruiting,A Randomized Controlled Trial on the Clinical Efficacy and Safety of Warm Meridians and Relieve Pain Plaster in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain (Cold Dampness Stasis Type).,Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain
